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1. Summary 
 
Wnt/β-catenin signaling plays a critical role in animal development and adult tissue 
homeostasis, including regulation of cell fate decisions, axial pattering, organogenesis 
and stem cell maintenance. Deregulation of Wnt signaling causes many human 
diseases, including cancer and osteoporosis. Wnt proteins constitute a large family of 
growth factors characterized by conserved cysteine and a lipid modification at their 
N-terminal half. Upon transport through a specialized secretary route they act as 
morphogens in variety of tissues by forming concentration gradient in the 
extracellular space. The post-translational addition of palmitate or palmitoic acid to 
Wnts renders them highly hydrophobic and is believed to control their membrane 
localization, it is unknown, however, how Wnts are recruited from the membrane to 
signaling complexes and how their signaling range is regulated. 
 
Wnts bind to Frizzled (Fz) seven transmembrane receptors and LRP5/6 co-receptors, 
which leads to stabilization of the transcription coactivation of β-catenin and 
activation of target gene. The structural basis of Wnt signaling by receptor binding 
has long been elusive. Only recently, the crystal structure of the Xenopus Wnt8-
Frizzled8-CRD complex was solved, but the significance of the interaction sites for 
signaling has not been assessed. In the present thesis, by using a structure-based 
mutagenesis approach, I present an extensive structure-function analysis of mouse 
Wnt3a by in vitro and in vivo evaluation. Evidence is provided for an essential role of 
Serine 209, Glycine 210 (site 1) and Tryptophan 333 (site 2) in Fz binding. 
Importantly, I discovered that Valine 337 in the site 2 binding loop is critical for 
signaling without contributing to binding. Mutations in the presumptive second CRD-
binding site (site 3) partly abolished Wnt binding, suggesting Fz dimerization as a 
necessary step in signaling. Intriguingly, most site 3 mutations increased Wnt 
signaling, probably by inhibiting Wnt-CRD oligomerization. In accordance, it was 
observed that increasing amounts of soluble Fz8-CRD protein modulated Wnt3a 
signaling in a biphasic manner.  Based on these finding, a model was developed, in 
which a concentration-dependent switch in Wnt-CRD complex formation from an 
inactive aggregation state to an activated, high mobility state, represents a modulatory 
mechanism in Wnt signaling gradients. 
Zusammenfassung 
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2. Zusammenfassung 
 
Der Wnt/β-Catenin Signalweg spielt sowohl in der Entwicklung als auch in der Homöostase 
tierischer Gewebe eine wichtige Rolle. So werden Prozesse wie die Determinierung des 
Zellschicksals, axiale Musterbildung, Organogenese und die Erhaltung der Stammzellnische 
durch ihn reguliert. Viele Erkrankungen wie Krebs oder Osteoporose sind in der 
Fehlregulation dieses Signalwegs begründet. Wnt-Proteine bilden als Wachstumsfaktoren eine 
große Familie, die durch konservierte Cysteine und eine Lipidmodifikation in ihrer N-
terminalen Hälfte charakterisiert ist. Nach dem Transport entlang eines spezialisierten, 
sekretorischen Wegs bilden sie einen Konzentrationsgradienten in der extrazellulären Matrix, 
wo sie in verschiedenen Geweben als Morphogene wirken. Palmitat und Palmitinsäure sind 
post-translationale Modifikationen der Wnt-Proteine, die ihnen einen stark hydrophoben 
Charakter verleihen und somit die Membranlokalisierung kontrollieren können. Es ist jedoch 
weder bekannt wie Wnt-Proteine von der Membran zu Signalkomplexen rekrutiert werden, 
noch wie ihre Signalintensität reguliert wird.  
Wnt-Proteine binden an die Transmembranrezeptoren der Frizzled (Fz)-Familie und die Co-
Rezeptoren LRP5/6, wodurch β-Catenin stabilisiert und eine Transkription von Zielgenen 
initiiert wird. Die strukturellen Grundlagen des Wnt-Signalwegs auf der Ebene der 
Rezeptorbindung blieben lange ungeklärt. Erst kürzlich wurde der Xenopus Wnt8-Frizzled8-
CRD-Komplex röntgenkristallographisch aufgeklärt, die Bedeutung der Interaktionsstellen für 
das Signalgeschehen auf biologischer Ebene blieb jedoch weiterhin offen. In der vorliegenden 
Arbeit wird eine ausführliche Struktur-Funktionsanalyse des murinen Wnt3a-Moleküls 
vorgelegt, welches durch eine struktur-basierte Mutagenese in vitro und in vivo charakterisiert 
wurde. Es wurde gezeigt, dass sowohl Serine 209, Glycine 210 (Region 1) als auch 
Tryptophan 333 (Region 2) essentiell für die Fz-Bindung sind. Darüber zeigte sich Valin 337 
in der Bindungsschleife der Region 2 als entscheidend für den Signalprozess, jedoch nicht für 
die Bindung. Weiterhin zeigten sich Hinweise darauf, dass die Dimerisierung der Fz-
Rezeptoren ein wichtiger Schritt bei der Initiierung des Signalwegs ist, da Mutationen in der 
präsumptiven, zweiten CRD-Bindungsregion (Region 3) zum Teil die Aktivität von Wnt3a 
inhibierten. Die meisten Mutationen in der Region 3 verstärkten jedoch die Signalstärke 
vermutlich durch die Inhibition der Wnt-CRD-Oligomerisierung. Unterstützt wird diese These 
durch die Beobachtung, dass steigende Konzentrationen an löslichem Fz8-CRD Protein die 
Wnt3a-Signalintensität biphasisch modulierten. Basierend auf diesen Ergebnissen wurde ein  
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Modell entwickelt, in welchem ein Übergang des Wnt-CRD Komplexes von einem inaktiven, 
aggregierten Zustand zu einem aktivierten, hoch mobilen Zustand in Abhängigkeit der CRD-
Konzentration postuliert wird, Dieser stellt einen neuen modulatorischen Mechanismus bei 
der Wnt-Gradientenbildung dar. 
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3. Introduction 
 
Cell-cell interactions through different signaling pathways play a crucial role in the 
coordination of embryonic development. In metazoans, at least 17 different types of 
signal transduction pathways operate, each pathway is used repeatedly during the 
development of an organism (Gerhart, 1999). The five major cell-cell signaling 
pathways, which control a vast majority of cell fate decisions during animal 
development are: the Hedgehog (Ingham & McMahon, 2001) TGFβ (including 
Nodal/BMP) (Shi & Massagué, 2003), Notch (Bray, 2006) receptor tyrosine kinase 
(EGF/FGF) (Tan & Kim, 1999) and Wnt (Logan & Nusse, 2004) pathways. Each 
pathway activates different subsets of target genes in different developmental 
contexts. Despite the existence of many pathways branches, only the β-catenin 
signaling branch has been implicated in body-axis specification. The Wnt signaling 
pathway is the main focus of this thesis and will be discussed in detail.  
3.1 The Wnt signaling pathway 
 
The Wnt signaling pathways are highly conserved among metazoans and have been 
demonstrated to be essential for animal development and tissue homeostasis. The 
aberrant Wnt signaling leads to varieties of diseases, including cancer, bone diseases, 
cardiovascular diseases (Cadigan & Nusse, 1997; Clevers, 2006; Logan & Nusse, 
2004; MacDonald et al, 2009). Wnt signaling also play an important role in 
dorsoventral axis specification. The specification of the dorsoventral axis coincides 
with the formation of an essential embryonic signaling centre known as the Spermann 
organizer in amphibians, the shield in zebrafish and the node in the mouse (Harland & 
Gerhart, 1997; Marlow, 2010; Schier & Talbot, 2005). The Wnt signaling pathway is 
tightly regulated by a large and complex array of proteins, which act as agonists and 
antagonists of signal transduction modulating Wnt signaling at different levels. There 
are generally considered to be three major branches of Wnt signaling based on 
different signaling mechanisms and biological responses.  
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(1) The β-catenin dependent pathway (canonical pathway), which operates though 
transcription control of target genes and regulates body axis pattering, cell fate 
specification, cell proliferation. 
(2) The β-catenin independent pathway (non-canonical pathway) also called 
Wnt/Calcium pathway, which activates Calcium-dependent cellular responses, 
and it is thought to antagonize Wnt/β-catenin signaling and mostly regulate cell 
migration. 
(3) The planar cell polarity pathway (PCP pathway) mainly involved in cytoskeletal      
changes and responsible for cell polarity and tissue movements.  
 
Most Fz proteins can activate all three pathways but with different efficiencies. The 
activation of a certain pathway is particularly dependent on the Wnt ligand, the co-
receptor and the cell type. 
 
3.2 Molecular mechanism of β-catenin dependent pathway 
(Canonical pathway) 
 
Canonical Wnt signaling controls cell specification and proliferation through the 
regulation of the transcription factor β-catenin, which activates the expression of 
numerous Wnt target genes (MacDonald et al, 2009; Marlow, 2010). When canonical 
Wnt signaling is inactive, a group of proteins named the destruction complex 
promotes β-catenin degradation resulting in the lack of β-catenin-inducible genes. 
The destruction complex consists of Axin, Adenomatous polyposis coli gene (APC), 
glycogen synthase kinase 3β (GSK3β) and casein kinase (CK1). Serine/threonine 
kinase CK1 and GSK3β phosphorylate the amino terminal region of β-catenin, which 
is subsequently ubiquitinated by β-Trcp E3 ubiquitin ligase resulting in its 
degradation (Liu et al, 2002; Yanagawa et al, 2002). This continual elimination of β-
catenin prevents it from reaching the nucleus and Wnt target genes are thereby 
repressed by the DNA-bound T cell factor/lymphoid enhancer factor (TCF/LEE) (Fig. 
1A). A hallmark of the canonical Wnt signaling pathway activation is the elevation of 
cytoplasmic free β-catenin protein levels. β-catenin is a bifunctional protein and 
exists in two separate pools in the cell. 
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Fig.1. Overview of the Wnt/β-catenin signaling pathway. (A) In the absence of Wnt 
ligands cytoplasmic β-catenin is constantly degraded and prospective target genes are in a 
repressed state. (B) Binding of Wnt to Frizzled and LRP5/6 receptors induces recruitment of 
Axin and Dishevelled (Dvl) to the membrane, thereby disrupting the destruction complex. β-
catenin can translocate into the nucleus and act as transcriptional co-activator.  Picture taken 
and modified from (Moon et al, 2004). 
 
At the membrane, it facilitates cell-cell adhesion by connecting E-cadherin to the 
actin cytoskeleton via α-catenin. The cytoplasmic soluble pool of the β-catenin is 
involved in the transmission of the Wnt signal from the membrane to the nucleus.   
The Wnt/β-catenin pathway is activated when Wnt ligands bind to seven-pass 
transmembrane receptor Frizzled (Fz) and its co-receptor, LRP5/6 and leads to the 
formation of Wnt-Fz-LRP5/6 trimeric complex. The cytoplasmic protein disheveled 
(Dvl) is recruited, phosphorylated and activated. Activation of Dvl promotes the 
dissociation of GSK-3β from Axin and leads to the inhibition of GSK-3β.  
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Phosphorylated LRP5/6, activates and recruits the Axin complex to the receptors, 
which leads to the inhibition of Axin-mediated β-catenin phosphorylation and thereby 
to the stabilization of cytoplasmic β-catenin, which accumulates and travels to the 
nucleus. Nuclear β-catenin is the ultimate effector, binding to Tcf/Lef (T cell factor 
and lymphoid-enhancing factor) transcription factors that lead to changes in the 
expressions of different target genes that regulate cell proliferation, differentiation, 
survival, cell polarity and even angiogenesis (Fig.1B). 
 
3.3 Wnt ligands and their Biogenesis  
Wnt ligand genes encode a family of evolutionary conserved secreted glycoproteins. 
Most mammalian genomes, including the human genome, which harbors 19 Wnt 
genes, categorized into 12 conserved Wnt subfamilies. Lower metazoans like Hydra 
and Nematostella also have an almost complete set of Wnt genes emphasizing the 
crucial role of Wnt signaling (Holstein, 2012). Sponges also contain few Wnt genes, 
whereas single-cell organisms do not have any Wnts, suggesting that Wnt signaling 
may have been instrumental in the evolutionary origin of the multicellular animals 
(Petersen & Reddien, 2009). 
 
All Wnt proteins share common characteristics: they are 350-400 amino acids long 
and have a corresponding molecular weight ~40 kDa and contain 22-26 conserved 
cysteine residues contributing to proper folding of the ligand (Coudreuse & 
Korswagen, 2007; Tanaka et al, 2002). Wnt proteins do not contain obvious domains 
that are shared with other proteins, except the N–terminal signal peptide that targets 
them to the secretory pathway. The primary amino acid sequence of Wnts contains 
several charged residues, and predicted to be soluble in aqueous solution, but when 
Wnt proteins were first isolated, a surprising finding was that they are highly 
hydrophobic (Bradley & Brown, 1990). The efficient production and biochemical 
characterization of Wnt proteins remains challenging. Mouse Wnt3a was the first 
purified and biochemically characterized Wnt (Willert et al, 2003). In addition to N-
glycosylation, which is required for Wnt secretion (Komekado et al, 2007), Wnt3a 
also undergoes two types of lipid modifications that are responsible for the 
hydrophobicity and poor solubility of Wnt proteins (Hausmann et al, 2007). 
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The first reported lipid modification was the addition of palmitate to cysteine 77 
(Willert et al, 2003). Mutation of Cys77 to Ala had minimal effect on Wnt3a secretion 
but diminished the ability of Wnt3a to activate Wnt signaling (Galli et al, 2007; 
Komekado et al, 2007; Willert et al, 2003). The second identified lipid modification 
was a palmitoleoyl attached to conserve serine 209 and its mutation leads to Wnt3a 
accumulation in endoplasmic reticulum (ER) and inhibits its secretion (Takada et al, 
2006). Wingless (Wg) protein from Drosophila is the most investigated Wnt molecule 
in vivo (Hausmann et al; 2007).  Porcupine encodes a multiple transmembrane ER 
protein that contains an O-acyl transferase domain, suggesting a role in Wg lipid 
modification (Hausmann et al; 2007). Porcupine deficiency results in Wg and Wnt3a 
accumulation in ER and inhibits Wnt3a palmitoleoylation at Ser 209 (Takada et al; 
2006), provides the evidence that Porcupine is responsible for this lipid modification. 
It has been certainly remains unknown whether Porcupine or a distinct acyltransferase 
is involved in Wnt3a palmitoylation at cysteine 77. 
 
In addition to this, two other proteins were indentified for Wg/Wnt secretion: Wntless 
(Wls) also known as Evenness interrupted (Evi) in Drosophila and the retromer 
complex in nematodes (Hausmann et al, 2007). Wls is a multipass transmembrane 
protein, which is localized to the Golgi, endocytic compartments and the plasma 
membrane, required for Wg secretion (Banziger et al, 2006; Bartscherer et al, 2006). 
The retromer complex mediates membrane protein trafficking between endosomes 
and the Golgi apparatus (Hausmann et al, 2007). Wnt proteins that are glycosylated 
and lipid modified by Porcupine in the ER and are escorted by Wls from the Golgi to 
the plasma membrane for secrection. Drosophila WntD protein neither requires 
Porcupine and Wls for secrection nor is palmitoylated at the conserved cysteine 
residue (Ching et al, 2008). 
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3.4 Structure of Wnt proteins  
It took almost 30 years to achieve the first high–resolution structure of a Wnt protein. 
The 3.25 Å crystal structure of Xenopus laevis Wnt8 in complex with mouse Fz8-
CRD has recently been solved by X-ray crystallography (Janda et al, 2012) (Fig. 2) 
and yielded important new insights into Wnt biochemistry. In the complex, XWnt8 
forms an unusual structure resembling a human hand with a central ‘‘palm’’ that 
extends a ‘‘thumb’’ plus an index ‘‘finger’’ to grab the Fz8-CRD on two opposite 
sides, without changing Fz8-CRD configuration. It reveals two-domain structure the 
NTD mainly containing α-helixes and the lipid-modified thumb.  A fatty acid adduct 
attached to serine 187 at the tip of the thumb, inserts into hydrophobic groove of Fz8-
CRD constituting the Wnt8-Fz8-CRD binding site 1 that has extensive hydrophobic 
interactions between the lipid and apolar residues of Fz8-CRD, in a ‘lipid in groove’ 
fashion. The remaining site 1 portion contributes to binding by protein-protein 
interactions between residues of the Wnt8 thumb loop and Fz8-CRD. The core 
structure of NTD has a saposin-like fold that superimposes well with bacterial 
atypical saposin-like protein, an ancient class of lipid binding and carrier domains 
(Bazan et al, 2012).The CTD constitutes the index finger and has two anti parallel β-
strands and a long intervening loop, which is stabilized by several disulphide bonds 
and engages in hydrophobic contacts within a depression of Fz8-CRD, in a  ‘knob-in-
hole’ fashion. This constitutes the Wnt8-Fz8-CRD interaction site 2. Both site 1 and 
site 2 are dominated by hydrophobic contacts, which are mostly mediated by 
conserved residues of Wnt8 and Fz8-CRD, suggesting a possible explanation for 
broad multiple specificity of Wnt-Fz interactions. A single Wnt can often binds to 
multiple Fz proteins and vice versa. However, residues of Wnt8 at both site 1 and site 
2, also exhibit protein-protein interactions with Fz8-CRD residues that are conserved 
in some but altered in other Fz proteins, suggesting certain selectivity on top of broad 
specificity in Wnt-Fz interactions.  
 
XWnt8 contains a region between the thumb and the index finger similar to the palm, 
where NTD and CTD corresponding to the region with the greatest flexibility among 
Wnt proteins, in particular, Wg carries a large insert of 80 amino acids not present in 
other Wnts. This Wg insert has been used to generate arguably the best antisera to any    
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Wnt protein (van den Heuvel et al, 1989), it also supports the model that the 
nonconserved linker region is solvent exposed and likely not involved in engagement 
to the Fz-CRD.Another potential interaction site observed in the crystal structure is 
called ‘‘pseudo-site 3’’ 
 
The residues involved in this interaction are poorly conserved among different Wnts. 
Pseudo-site 3 was suggested to be responsible for formation of asymmetric dimers in 
the crystal generating a repeating oligomer. Thus it may account for Wnt-induced 
receptor clustering and signalosome assembly. However it could also be an artifact 
due to crystal packing. The physiological relevance of pseudo-site 3 still remained to 
be examined. 
 
 
 
Fig.2. Crystal structure of XWnt8-Fz8-CRD complex (A) Surface representation of 
XWnt8 bound to mFz8-CRD. N-linked glycosylation of Wnt8 marked with green clusters 
and Palmitoleic acid (PAM) is shown in red. (B) Secondary structure of Xwnt8. The 
conserved 22-cysteine residues are numbered to indicate the pairs that form disulphide 
bridge is shown by orange lines. N-linked glycosylation sites are shown by green cartoon. 
Picture taken from (Janda et al, 2012). 
 
Introduction  
	   11	  
 
William Weis’ laboratory recently reported the 2.5Å resolution crystal structure of a 
Drosophila WntD fragment encompassing the N-terminal domain and the linker that 
connects it to the C-terminal domain (Chu et al, 2013). There are some differences in 
the structure of WntD and Xenopus Wnt8. Usually all Wnt proteins have a conserved 
serine residue at the tip of the β hairpin that connects two helices.  This residue is 
modified by lipidation in Wnt3a (Ser209). WntD, however contains a glutamine 
residue rather than a serine at this position. In the WntD the tip of the hairpin folds 
back to create a fist-like structure, which is stabilized by a hydrogen bond. However, 
the tip of the XWnt8 hairpin forms an extended conformation and is stabilized by the 
lipid contact with the Fz8-CRD. An unusual feature of the WntD structure is the 
presence of a large solvent filled cavity between helices A C D E, however this cavity 
is much narrower in XWnt8. 
 
3.5 Frizzled receptors and their interaction with Wnts  
Calvin Bridges discovered a recessive Drosophila mutant, which he called frizzled 
(fz) and which was responsible for irregularly orientated hairs and ommatidia. The Fz 
family comprises 10 members in humans, and Fz proteins were the first Wnt receptors 
identified (Bhanot et al, 1999). The topology of all frizzled receptors is similar to G 
protein-couple receptors (GPCR) (Vinson et al, 1989). They are the most widespread 
Wnt receptors and induce both β-catenin-dependent and β-catenin-independent 
signaling. The identified Fz receptors contain common structural features, which 
includes a highly conserved cysteines-rich domain (CRD) at the amino-terminus, a 
seven-transmembane domain and a short cytoplasmic tail at the carboxy-terminus 
(Fig. 3A). The highly conserved CRD domain (10 cysteine), mediates high-affinity 
interactions with Wnt proteins (Hsieh et al; 1999). However, recent finding suggest 
that proteins from other families- sFRPs, R-spondin and Norrin can also directly bind 
to Fzs and activate downstream signaling cascade (Nam et al, 2007; Rodriguez et al, 
2005; Smallwood et al, 2007; Xu et al, 2004). The sFRPs were initially seen as Wnt 
antagonists that prevented Wnt binding to Fz. However, there are some reports, which 
suggested that direct binding of sFRPs to Fz-CRDs probably occur by CRD 
dimerization (Bafico et al, 1999), which leads to the receptor activation.... 
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(Rodriguez et al, 2005). Receptor dimerization through CRD/CRD interaction in 
particular olimomerization, appears to be important for Fz maturation and proper 
exposure to the proteins at the cell membrane it has been shown for Fz1 and Fz4 
(Kaykas et al, 2004). 
 
 
       
Fig.3. Frizzled structure. (A) Schematic representation of Frizzled protein. SS, signal 
sequence; CRD, cysteine-rich domain. The CRD is extracellular and binds to Wnts. The C- 
terminus is intracellular and contains a proximal KTXXXW motif. (B) Crystal structure of the 
mFz8-CRD as dimer, α-helices in blue, 310 –helices in yellow, β-strands in green, coil in gold. 
Disulphide bonds are shown as ball-and-stick model in yellow and black. Picture taken from 
(Dann et al, 2001; Huang & Klein, 2004).  
 
The potential Wnt binding sites of the CRD have been mapped using a binding assay 
that detects direct binding of XWnt8 to the CRD tethered to plasma membrane 
through glycophosphotidylinositol (GPI) anchor (Hsieh et al, 1999). The CRDs of Fz1  
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and Fz2 in Drosophila and Fz8 in mice have been shown to bind to Wnt proteins with 
nanomolar affinity (Hsieh et al, 1999; Rulifson et al, 2000; Wu & Nusse, 2002). 
However, the mutated Fz receptors that omit the CRD domain may still be able to 
bind Wnt ligands and influence signaling activity, but less efficiently than their wild 
type counterparts (Chen et al, 2004; Povelones & Nusse, 2005). In addition to this, it 
has been found that when these mutated Fz receptors are fused with either other Wnt 
ligand-binding domain or directly linked to other Wnt ligands, they are capable to 
restore the Wnt signaling activity (Cadigan & Liu, 2006; Chen et al, 2004; Povelones 
& Nusse, 2005). These findings collectively suggest that the CRD functions as 
binding domain for Wnt ligands, which is indispensable.  
 
The finding that the CRD of Fz is indispensable for Wnt/-β catenin signaling is not 
incompatible with the model that Wnt ligands induce the Fz-LRP oligomerization but 
argues against the idea that Wnt acts as an adaptor between the two co-receptors. It is 
more likely possible that binding of Wnt to LRP induces a conformational change that 
makes binding to Fz favorable.  Constitutively active Wnt-FzΔCRD fusion proteins 
could bind to LRP. Indeed, it has been reported that Wnt-FzΔCRD fusion protein 
requires β-catenin for its signaling activity (Povelones & Nusse, 2005). The role of Fz 
receptors in Wnt signaling has now clearly been established; however, the specificity 
of the interaction between the various Wnt ligands and Fz receptors remains elusive. 
This is probably due to the large number of Wnt ligands and Fz receptors, the 
potential multitude of Wnt/Fz interactions and because of mutual functional 
redundancies in both the ligands and receptors (He et al, 2004). 
 
The crystal structure of mouse Fz8-CRD shows that the CRD consists mainly of α-
helical stretches and two short sequences forming a minimal β-sheet at the N-
terminus representing a novel protein fold (Dann et al, 2001) (Fig. 3B). A ligand-
binding surface was predicted from the analysis of the crystal structure integrated by 
comprehensive mutagenesis. It has been found that the CRD forms a conserved dimer 
interface, although in solution they appear to exist as monomer. Dimerization of Fz-
CRD has a role in activation of Wnt/β-catenin signaling (Carron et al, 2003). 
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Further regulation of Fz receptors can occur through intracellular binding to 
cytoplasmic partners, primarily through the Fz cytoplasmic tail or the intracellular 
domain. The key cytoplasmic partner of Fz is a scaffold protein called Dishevelled 
(DVL), which interacts with most Wnt co-receptors and transduces all major Wnt 
subpathways. Fz engages with DVL proteins through a highly conserved KTXXXW 
motif (Kikuchi et al; 2011). Once ligands binds to Fz, DVL proteins are recruited to 
Fz receptors at the plasma membrane, and co-recruit other cytoplasmic transducers, 
such as axin, GSK3 and CK1, presumably along with their partners, to promote β-
catenin-dependent signaling. It has been found that DVL itself can form oligomers 
(Schwarz-Romond et al, 2007), which might be responsible for clustering Wnt-Fz 
receptor complexes and promote endocytosis and downstream signaling (Bilic et al, 
2007). 
 
 
3.6 Other Wnt Co-receptors: LRP5/6, ROR2 and Ryk 
The complexity of Wnt/Fz signaling is further increased by the discovery of co-
receptors for Fz and alternative Wnt receptors. In general co-receptors are cell surface 
proteins that associate with a ligand or its primary receptor to enhance complex 
formation and downstream signaling. In β-catenin-dependent signaling, Wnt-Fz forms 
a ternary complex with LRP5/6, whereas in the PCP signaling pathway they interact 
with ROR or PTK7 (Hikasa et al, 2002; Nishita et al, 2010; Oishi et al, 2003). 
Frizzled can also engage with RYK to activate β-catenin-dependent, PCP and Wnt-
Ca2+ downstream pathways (Fig.4). 
 
Members of the low-density lipoprotein receptor related protein family, LRP5 and 
LRP6, are now well recognized as co-receptors in β-catenin-dependent signaling (He 
et al; 2004). The extracellular domain (ECD) engages with Wnt and Fz and forming a 
ternary complex, the ECD contains multiple, independent Wnt-binding sites, which 
allow different Wnts to bind simultaneously in conjunction with Fz (Bourhis et al, 
2010). The main mechanism of regulating LRP6 function is through phosphorylation 
of its intracellular domain (ICD) which is sufficient to activate β-catenin-dependent 
signaling (Bourhis et al, 2010; Zeng et al, 2005). The ICD contains five PPPSXP  
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motives, phosphorylation of which is required for β-catenin-dependent signaling. 
GSK-3β is the master negative regulator of β-catenin, mediating phosphorylation of 
the PPPSXP site in response to Wnt signaling and thus plays both a positive and 
negative role in β-catenin-dependent signaling (Zeng et al, 2005). 
 
 
                           
Fig.4. Different Wnt receptors on the cell membrane. Picture taken from Wnt homepage       
(http://www.stanford.edu/~rnusse/frizzleds/receptors.html). 
 
CKIγ, a member of CKI mediates phosphorylation at adjacent Ser residues 
(PPPSPXS), which is required for Wnt signaling (Davidson et al, 2005). LRP6 may 
also be regulated through cleavage by complement component C1q (Naito et al, 
2012). 
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In the presence of C1q, the LRP6 ECD is cleaved, which activates β-catenin-
dependent signaling. 
 
Another Wnt binding receptor is ROR, an orphan receptor that is member of the 
tyrosine kinase family. RORs share the cysteine-rich domain (CRD) with Fz (Kani et 
al, 2004; Mikels & Nusse, 2006). ROR1 and ROR2 bind Wnt5a and mostly activate 
PCP signaling in vertebrates (Hikasa et al, 2002; Oishi et al, 2003). Wnt5a is the 
principal ROR ligand in vivo. Wnt5a binding induces homodimerization of ROR2 
(Liu et al, 2008) and formation of a ternary complex with Fz (Grumolato et al, 2010; 
Sato et al, 2010), which leads to the recruitment of Dvl, Axin, GKS3, which 
ultimately activates the receptor (Grumolato et al, 2010; Nishita et al, 2010; Witte et 
al, 2010). ROR2 is also activated by forced dimerization (Green et al, 2008). 
 
Apart from ROR, Ryk also called Derailed in Drosophila is a member of 
transmembrane tyrosine kinases. These have a Wnt binding domain similar to the 
WIF proteins, a group of Wnt binding factors(Hsieh et al, 1999). They play an 
important role in the central nervous system particularly in axon guidance and 
neuronal cell fate determination (Clark et al, 2012; Kikuchi et al, 2011).  
 
3.7 Extracellular Regulation of Wnt signaling 
 
Wnt signaling is regulated at different levels by a wide range of effectors. These 
effectors function as antagonists or agonists and perform their function either 
intracellularly to regulate components of the signal transduction machinery or 
extracellularly to modulate ligand-receptor interactions. Antagonist and agonist play 
critical roles, as they control the fine-tuning of Wnt signaling and are able to inhibit or 
activate Wnt-regulated developmental processes for example anterior-posterior (AP) 
axial patterning, angiogenesis, somatogenesis, bones, limbs and eye formation. 
Aberrant Wnt signaling also leads to many pathological events such as cancer and 
bone disease. Secreted Frizzled-related proteins (sFRPs) and Wnt inhibitory protein 
(WIF) bind to Wnt ligands and in the case of sFRPs also to  Fz, and therefore they  
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function as Wnt antagonist for both β-catenin and noncanonical signaling (Bovolenta 
et al, 2008). Based on biochemical and functional analyses using cultured cells and 
Xenopus embryos it was shown that Frzb/sFRP3 binds to XWnt8 and Wnt1 and 
inhibits Wnt/β catenin signaling (Leyns et al, 1997; Wang et al, 1997). These results 
suggest a model wherein sFRPs inhibit Wnt signaling by sequestering Wnt ligands 
away from active receptor complex (Fig. 5). It has been found that the CRD domain  
 
 
Fig.5. Possible mechanism by which sFRPs could modulate Wnt signaling (A) sFRPs 
could sequester Wnt either through NTR or CRD domain, therefore acting Wnt antagonists. 
(B) They could dimerized via CRDs and thereby favouring Wnt signaling. (C) sFRPs, could 
form inactive complexes by binding to Fz-CRD thereby preventing signal transduction by 
Wnt ligands. (D) sFRPs might favour a Wnt-Fz interaction by simultaneously binding to both 
molecules and promoting signal transduction. Picture taken from (Bovolenta et al, 2008). 
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of Frzb seemed to be necessary and sufficient for both activities, Wnt binding and 
inhibition (Lin et al, 1997). In contrast, a mutant form of sFRP1 lacking the CRD 
domain retained the ability to bind to Wg, whereas deletion of the NTR resulted in a 
reduction or loss of Wg binding (Uren et al; 2000). Furthermore a recent report on 
sFRP1 combining biochemical and functional assay in cell culture and medaka 
embryos showed that its NTR domain that mimics the function of entire molecule in 
binding Wnt8 and inhibiting Wnt signaling. These apparently contradictory results 
might imply that sFRPs have multiple Wnt-binding site and sFRP-Wnt pairs associate 
with different affinities.  
 
The crystal structure of the CRD from mouse Fz8 and mouse sFRP3 revealed the 
potential for the CRDs to dimerize (Dann et al, 2001). This suggests the ability of 
sFRP and Fz proteins to form homo- and heteromeric complexes through the CRD 
domain(Bafico et al, 1999; Rodriguez et al, 2005). These findings suggest an 
alternative explanation of how sFRPs could inhibit Wnt signaling by forming inactive 
complexes with Fz receptors (Fig.5C). sFRPs are not only inhibiting Wnt/β signaling 
but also inhibits noncanonical Wnt/PCP signaling (Li et al, 2008; Matsuyama et al, 
2009; Satoh et al, 2008; Sugiyama et al, 2010) which is not surprising, as they bind to 
both types of Wnts.  
 
The Wnt-binding property suggesting that sFRPs and WIF may also be involved in 
the regulation of Wnt stability and diffusion/distribution extracellularly beyond just 
Wnt inhibitors. It was shown that sFRPs could expand a signaling range of Wnt8 
despite their molecular function as Wnt inhibitors, suggesting another regulatory 
mechanism for Wnt signaling (Mii & Taira, 2009).  
Two distinct classes of Wnt inhibitors including the Dickkopf (Dkk) family and the 
WISE/SOST family. Dkk1, which is LRP5/6 ligands/antagonists and considered as 
specific inhibitors of Wnt/β-catenin signaling. Dkk1 inhibits canonical Wnt signaling 
by binding to LRP5/6 and another single transmembrane protein Kremen 1 (Krm1) 
and Kremen 2 (Krm2) (Mao et al, 2002). Krm, Dkk1 and LRP6 form a ternary 
complex at the cell surface and disrupt Wnt/LRP6 signaling by promoting endocytosis  
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and removal of the Wnt receptor (LRP6) from the plasma membrane (Mao et al, 
2002). Like Dkk1, SOST is also able to disrupt Wnt-induced Fz-LRP6 complex 
formation in vitro (Semenov & He, 2006). 
Shisa proteins represent a distinct family of Wnt antagonists that trap Fz proteins in 
the ER and prevent Fz from reaching the cell surface, thereby inhibiting Wnt 
signaling (Yamamoto et al, 2005). Other Wnt antagonists like Xenopus Cerberus 
binds to and inhibits Wnt as well as Nodal and BMP signaling (Piccolo et al; 2009). 
Insulin-like growth-factor (IGF) binding protein-4 (IGFBP-4) also inhibits Wnt 
signaling via binding to both Fz and LRP6, in addition to modulating IGF signaling 
(Zhu et al, 2008). Recently Tiki1 was identified by functional cDNA screening as an 
organizer-specific gene, required for anterior neural development in Xenopus (Zhang 
et al, 2012). Tiki1 inhibits Wnt signaling by removing eight amino-terminal residues 
from Wnt itself, which leads to the formation of oxidized Wnt oligomers with 
impaired receptor-binding capability (Zhang et al, 2012). 
Norrin and R-spondin (Rspo) proteins are two families of agonists for Wnt/β-catenin 
signaling. Norrin is a specific ligand for Fz4 and LRP5/6 during retinal 
vascularization (Xu et al, 2004). R-Spondins (Rspo 1-4) are a small family of secreted 
growth factors, which in addition to Wnt, potently activate β-catenin signaling.  Rspos 
synergize with Wnts (Kazanskaya et al, 2004; Kim et al, 2005; Kim et al, 2008; Nam 
et al, 2006) and require the presence of Wnts to activate β-catenin signaling (Binnerts 
et al, 2007). Rspo binds to the extracellular part of ZNRF3 and promotes the 
interaction between ZNRF3 and LGR4, which results in ZNRF3 clearance from the 
membrane. This report suggest a model where in Rspo activates Wnt signaling by 
inhibiting ZNRF3 in an LGR4-dependent manner, resulting in the accumulation of 
Wnt receptors at the cell surface. 
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3.8 Wnt/β-catenin signaling in Cancer and other diseases 
 
Wnt/β-catenin signaling plays a critical role in development and homeostasis. 
Mutations of the Wnt pathway components are associated with many hereditary  
disorders, cancer and other diseases (van Amerongen & Nusse, 2009). Mutations in 
Porcupine (PORCN), various Wnt ligands, agonists and antagonists have shed light 
on Wnt regulation in human development.  Given the diverse phenotypes produced by 
Wnt knockouts in mice, it is not surprising that loss of Wnts in humans has direct 
consequences as well.  A non-sense mutation in the Wnt3 gene causes the autosomal 
recessive disorder terta-amelia, a rare human genetic disorder characterized by 
complete absence of all four limbs and other anomalies (Niemann et al, 2004).  
 
Recently it has been reported that hypofunctional alleles of Wnt1 cause autosomal-
recessive osteogenesis imperfecta (OI), a congenital disorder characterized by 
reduced bone mass and recurrent fractures (Keupp et al, 2013). Another recent report 
on the naturally occurring Wnt1 mutation of valine to phenylalanine at V335 causes 
osteogenesis imperfecta through impaired Wnt signaling (Fahiminiya et al, 2013). 
Mutation in Wnt10A is associated with Odonto-onycho-dermal dysplasia, which is a 
rare autosomal recessive syndrome in which the phenotype includes dry hair, severe 
hypodontia, smooth tongue, hyperkeratosis of skin (Adaimy et al, 2007). A genetic 
evaluation revealed that loss-of-function mutation in Wnt4 gene. Wnt4 appears to be 
important in the development and maintenance of the female phenotype in women 
(Lauber et al; 2004). 
 
Mutations in either LRP5 or Fz4 are associated with familial exudative 
vitreoretinopathy (FEVR) (Toomes et al, 2004), which is manifested by defective 
retinal vascularization, also seen in Norrie disease carrying Norrin mutations, leading 
to the identification of Norrin as a ligand for Fz4 and LRP5(Xu et al, 2004). One fast 
growing field involves Wnt/β-catenin regulation of bone mass, as osteoporosis 
remains a global health problem. This was triggered by the discovery of LRP5 loss-
of-function mutations in patients with osteoporosis pseudoglioma syndrome (OPPG), 
a recessive disorder characterized by low bone mass and abnormal eye vasculature 
(Gong et al, 2001).  
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Conversely patients with autosomal dominant high bone mass (HBM) diseases harbor 
LRP5 missense (‘gain-of-function’) mutations (Boyden et al, 2002; Little et al, 2002), 
which are clustered in the LRP5 extracellular domain and render LRP5 resistant to 
binding and inhibition by the antagonist SOST (Ellies et al, 2006; Semenov & He, 
2006) and Dkk1 (Ai et al, 2005). Interestingly mutations in the SOST gene causes 
Sclerosteosis. Thus LRP5 activity correlates with bone mass likely via regulation of 
osteoblast) proliferation, whereas SOST and Dkk1, which are specifically expressed 
in osteocytes, negatively regulate bone mass by antagonizing LRP5. Moreover, 
deletion of sFRP1 or Dkk1 enhances bone formation further suggesting that Wnt 
signaling is required for the maintenance of normal bone density (Bodine et al, 2004). 
 
Mutations in intracellular pathway components can also cause dramatic defects. A 
Finnish family with severe tooth agenesis (oligodontia) and colorectal neoplasia was 
studied recently and identified the cause to be a nonsense mutation in AXIN2. This 
mutation introduces a premature stop codon to exon 7 of the AXIN2 gene leading to a 
truncated protein lacking the C-terminal domain. The AXIN2 mutation is one of the 
rare cases in which a mutation simultaneously predisposes to cancer and causes a 
hypoplastic malformation (Lammi et al, 2004). Mutations that promote constitutive 
activation of the Wnt signaling pathway lead to cancer. The best-known example is 
Familial Adenomatous Polyposis (FAP), an autosomal, dominantly inherited disease 
in which patients display polyps in the colon and rectum. This disease is caused most 
frequently by truncations in APC (Kinzler et al, 1991; Nishisho et al, 1991) that 
promote aberrant activation of the Wnt pathway leading to adenomatous lesions due 
to increased cell proliferation. Mutations in β-catenin and APC have also been found 
in sporadic colon cancers and a large variety of other tumor types (Giles et al, 2003; 
Polakis, 2007). Loss-of-function mutations in Axin have been found in hepatocellular 
carcinomas(Satoh et al, 2000). These examples clearly demonstrate that the 
uncoupling of normal β-catenin regulation from Wnt signaling control is an important 
event in the genesis of many cancers. 
 
In the colon, loss of TCF4 or Dkk over-expression promotes loss of stem cells in the 
colon crypt, indicating that Wnt signaling is required for the maintenance of the stem  
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cell compartment (Korinek et al, 1998; Kuhnert et al, 2004). Wnt signaling may 
therefore be a fundamental regulator of stem cell choice to proliferate or self-renew. 
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4. Aim of Thesis 
 
Wnts are secreted glycoproteins that play critical roles in embryonic development, 
cell fate determination and stem cell renewal. The Wnt/β-catenin signaling is initiated 
by binding of Wnt protein to a Frizzed (Fz) receptor and a coreceptor, LRP5/6. The 
molecular basis of Wnt signaling by the engagement of Frizzled receptors has long 
been unknown due to the lack of structural data on Wnt ligands. Only recently, the 
crystal structure of the XWnt8-Frizzled8-CRD complex was solved, but the 
significance of the interaction sites for signaling was not assessed  
The aim of this thesis was to provide functional data on mouse Wnt3a-Frizzled8 
interaction to answer the following questions 
1. What are the biological significances of sites 1, 2, 3 in Wnt3a-Frizzled8-CRD 
interactions in vitro and in vivo? 
2. To understand how lipid modified Wnts are recruited from the plasma 
membrane to the signaling complexe 
3. How binding to the Fz-CRD-related proteins regulates the Wnts signaling 
range in the extracellular space?  
To answer these questions, I performed an extensive mutagenesis analysis and tested 
Wnt isoforms mutated at critical site 1, 2 and pseudo site 3 residues both in vitro 
using Wnt reporter assays and in vivo in Xenopus and zebrafish embryos. 
Further, the influence of the Fz8-CRD on the Wnt3a signaling potential was 
investigated by applying soluble Fz-CRD-Fc proteins on Wnt producing cells and 
monitoring the response in a simulated auto/paracrine or endocrine context.  	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5. Materials and Methods  
 
5.1 Materials         
   
5.1.1 Chemicals  
All chemicals that were used in this study are listed in alphabetical order of the 
company from where they were purchased. The chemical and enzymes were acquired 
as the highest purity available. 
Table 1: Chemicals in alphabetical order of companies 
Company Compounds 
AppliChem 
Darmstadt (Germany) 
agar, disodiumm hydrogen phosphate, EDTA, glycerol, 
glycine, isopropyl alcohol, kanamycin sulphate, 
magnesium choloride, Nonidet P40, sodium acetate, 
trypton, X-Gal,  
Eurogentec (Köln) 
Germany) 
Wnt3a synthetic peptides  
 
Merck Darmstadt (Germany) 
 
calcium chloride dihydrate, formaldehyde, glacial acetic 
acid, hydrogen peroxide, imidazole, Triton X-100 
 
Qiagen (Germany) Ni-NTA Agarose  
 
Roche Diagnostics 
GmbH, Mannheim (Germany ) 
Protein A agarose 
Roth 
Karlsruhe (Germany) 
acrylamide/bisacrylamide (Rotiphorese Gel 40 (29:1)), 
agarose,ampicillin, β-mercaptoethanol, DTT, milk 
powder (blotting grade), sodium dihydrogen phosphate 
dihydrate, TEMED, Tris, Tween 20 
Serva Heidelberg (Germany) sodium azide, sodium dodecyl sulfate, 
 
Sigma St. Louis, Missouri 
(USA) 
Bovine serum albumin fraction V, CHAPS, ethanol, 
VWR International 
West Chester, 
Pennsylvania (USA) 
ammonium acetate, hydrochloric acid 
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5.1.2 Equipments  
Table 2: List of Technical equipments used in this study 
 
 
 
 
Technical equipment Company 
Benchtop centrifuge  Thermo Fisher Scientific); Waltham, Massachusets 
(USA) 
 
Centrifuge Beckman Coulter GmbH Krefeld    (Germany) 
 
Centrifuge for tissue culture  Beckman Coulter GmbH Krefeld (Germany 
CO2-incubator  Heraeus (Hanau)  
 
Developer machine  Agfa- Gevaert N.V, Mortsel (Belgium) 
Electroporation apparatus BioRad Laboratories GmbH; 
München (Germany) 
Gel documentation system Intas Science Imaging 
Instruments GmbH; 
Göttingen (Germany) 
Incubation shaker for cultivation 
of bacteria 
Infors HT; Bottmingen 
(Switzerland) 
Inverted confocal microscope Nikon Instruments Europe B.V.; 
Kingston, Surrey (England) 
Inverted fluorescence microscope Nikon Instruments Europe B.V.; 
Kingston, Surrey (England) 
PCR machine MyCycler BioRad Laboratories GmbH; 
München (Germany) 
Protein blotting cell BioRad Laboratories GmbH; 
München (Germany) 
Protein gel system peqlab; Erlangen (Germany) 
Multimode microplate reader Berthold Technologies (Germay) 
Nanodrop ND-1000 peqlab; Erlangen (Germany) 
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5.1.3 Enzymes 
DNaseI, Proteinase K, various restriction enzymes, T4 DNA ligase, T4 DNA 
polymerase, Precisor high-fidelity DNA polymerase, Phusion® High-Fidelity DNA 
Polymerase Products Suppliers: New England Biolabs, Gibco, Promega, Fermentas  
 
5.1.4 Kits  
BCA protein assay kit (Pierce), Dual luciferase assays kit (Promega),  mMESSAGE 
mMACHINE® SP6 in vitro transcription kit (Ambion). Wizard Plus SV Minipreps 
DNA purification system and Wizard SV Gel and PCR Clean-Up system (Promega). 
QIAGEN plasmid Midi kit (Qiagen). 
 
5.1.5 Antibodies  
Table 3: List of Primary and secondary antibodies 
 
Antibody  Species Dilution Source 
Primary antibodies     
Anti-Wnt3a  rabbit (polyclonal) 1:1000 Abcam 
Anti- α-tubulin  mouse 1:1000 Sigma 
Anit-Penta-His      mouse  1:1000 Qiagen 
Secondray antibodies    
Goat-anti-Mouse HRP  goat IgG (L+H) 1:10000 Jackson 
Goat-anti-rabbit HRP  goat IgG (L+H) 1:10000 Jackson 
Goat-anti-human IgG  goat (Fc specific) 1:100000 Sigma 
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5.1.6 Buffer, Antibiotics and Media  
 
1.5 M Tris-HCl pH 8.8: Dissolve 181.71 g Tris base in 900 ml H2O. Adjust pH to 
8.8 with HCl. Adjust volume to 1 litre with H2O. Sterilize by autoclaving. 
 
1.5 M Tris-HCl pH 6.8: Dissolve 181.71 g Tris base in 900 ml H2O. Adjust pH to 
6.8 with HCl. Adjust volume to 1 litre with H2O. Sterilize by autoclaving. 
 
10% SDS: Dissolve 10 g SDS in 90 ml H2O. Adjust volume to 0.1 litre with H2O. 
Store at room temperature. 
 
10% APS: Dissolve 0.1 g APS in 1 ml H2O. Prepare freshly prior to use. 
 
10 x SDS-PAGE running buffer: 10 g SDS, 30.3 g Tris base, and 144.1 g glycine 
Dissolve in 800 ml H2O. Adjust volume to 1 litre with H2O. 
 
2 x SDS-PAGE sample buffer: 100 mM Tris-HCl pH 6.8, 20 % Glycerol (v/v), 4 % 
SDS (w/v), 100 mM DTT (just before use). 
 
5 x SDS-PAGE sample buffer:  250 mM TrisHCl pH6.8, 10% SDS, 30%Glycerol, 
0.02% bromophenol blue, 500 mM DTT (just before use) 
Gel Staining solution: 10% acetic acid 0.1% Coomassie Brilliant Blue G-250 (w/v). 
 
Gel destaining solution: 20% acetic acid (v/v), 10% ethanol (v/v). 
 
0.5 M EDTA: 186.12 g EDTA in 800 ml H2O. Adjust pH to 8.0 with NaOH. Adjust 
volume to 1 litre with H2O. Sterilize by autoclaving. 
 
50 x TAE: 242 g Tris base 100 ml 0.5 M EDTA (pH 8.0) 57.1 ml glacial acetic acid 
Adjust volume to 1 litre with H2O. 
 
6 x DNA loading dye: 0.09% bromophenol blue (w/v) 0.09% xylencyanol (w/v) 60% 
glycerol (v/v) 60 mM EDTA (pH 8.0) 
10 x PBS:  80g NaCl, 2g KCl, 2g KH2PO4, 15.4g Na2PO4.2H2O. Sterilize by 
autoclaving. 
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10 x Transfer Buffer (Blot Buffer):  30.285g Tris, 112.605g Glycin, to make 1X 
transfer buffer add, 10x methanol.  
LB-medium: 10 g tryptone, 5 g yeast extract, 5 g NaCl. Adjust volume to 1 liter with 
H2O. Sterilize by autoclaving. 
 
LB-agar plates: 10 g tryptone, 5 g yeast extract, 5 g NaCl, 15 g agar. Adjust volume 
to 1 liter with H2O. 
 
SOC-medium: 20 g tryptone, 5 g yeast extract, 0.5 g NaCl, 2.5 mM KCl. Adjust 
volume to 1 liter with H2O. Sterilize by autoclaving. Add MgCl2 to a final 
concentration of 10 mM and glucose to 20 mM. 
 
Ampicillin stock-solution: 100 mg/ml in H2O. Sterilize by filtration. Store at 
200C.Working concentration: 100 µg/ml 
 
IPTG (1 M): 1 g IPTG (FW 238.3) resolved in 4.2 ml (~4 ml) H2O, filter through 
0.22 µm filters, aliquot 1 ml in eppendorf. Store at -20oC. 
 
 DTT (1 M): 5 g DTT (FW 154.25) resolved in 32.5 ml (~30 ml) 10 mM NaAc (pH 
5.2), filter through 0.22 µm filters, aliquot 1 ml in eppendorf. Store at -20oC. 
 
X-gal (20mg/ml): Add 5 ml (~4.8 ml) DMSO into 100 mg X-gal bottom (FW 
408.24). Store at -20oC.  
 
5.1.7 Primers  
All primers were purchased from Eurofins MWG Operon (Ebersberg, Germany). 
Primer stock solutions of 100 pmol were stored at -20 0C. 
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Table 4: List of primers used in this study  
 
Construct Forward primer (5’→3’) Reverse primer  (5’→3’) 
pCS2-mWnt3a CGCGGATCCATGGCTCCTCTCGGATA
C 
CGCCTCGAGCTACTTGCAGGTGTGC
AC 
pCS2-mWnt3a-His CGCGGATCCATGGCTCCTCTCGGATA
C 
AAACTCGAGCTAGTGATGGTGATGG
TG 
ATGCTTGCAGGTGTGCACGTCATAG     
pCEP-Pu-mWnt3a-His CGCGCTAGCGAGCTACCCGATCTGGT
GG 
GCGGCCGCCTTGCAGGTGTGCACGT
C 
pFUSE-hIgG3*01-Fc2 – m 
mFz8-CRD 
AAAGAATTCGGCTTCGGCCAAGGAG
CTGGC 
AAAAGATCTGCTGGGCGCGGCCGTG
G 
pCEP-Pu-–mWnt3a- 
Fz8-CRD-His 
TTTGCGGCCGCAGCTTCGGCCAG 
GAGCTGGCGTG 
GGATCCCTAGTGATGGTGATGGTGA
TG GCTGGGCGCGGCCGTGGTGAG 
pCS2-Wnt3a-NTD TTTGGATCCATGGCTCCTCTCGGATA
C 
AAACTCGAGCTAGGCCTCGTAGTAG
AC CAG 
pCS2-Wnt3a-CTD TTTGGATCCATGGCTCCTCTCGGA         AAACTCGAGCTACTTGCAGGTGTGC
AC GTC 
pCS2-Wnt3a-NTD-His  TTTGGATCCATGGCTCCTCTCGGATA
C 
AAACTCGAGCTAGTGATGGTGATGG 
GATGGGCCTCGTAGTA 
pCS2-Wnt3a-CTD-His TTTGGATCCATGGCTCCTCTCGGA        CACCTGCAAGCATCATCATCAT CAT 
CAT TAG CTCGAG TTT 
Point Mutants  
  
pCS2-Wnt3a- I45R CATTCTCTGTGCCAGCAGACCAGGCC
TGGTACG 
CGGTACCAGGCCTGGTCTGCTGGCA
CAGAGAATG 
pCS2-Wnt3a-Y59A GCTTCTGCAGGAACGCCGTGGAGATCATGCCC 
GGGCATGATCTCCACGGCGTTCCTGC
AGAAGC 
pCS2- Wnt3a -V60R CTGCAGGAACTACAGAGAGATCATGCCCAG 
CTGGGCATGATCTCTCTGTAGTTCCT
GCAG 
pCS2- Wnt3a -M63A 
CTACGTGGAGATCGCCCCCAGCGTG
GCTGAG 
 
CTCAGCCACGCTGGGGGCGATCTCC
ACGTAG 
pCS2- Wnt3a -P64A CTACGTGGAGATCATGGCCAGCGTGGCTGAGGGTG 
CACCCTCAGCCACGCTGGCCATGAT
CTCCACGTAG 
pCS2- Wnt3a - A67R ATGCCCAGCGTGAGAGAGGGTGTCAAA 
TTTGACACCCTCTCTCACGCTGGGCA
T 
 
pCS2- Wnt3a -E68A CATCCCAGCGTGGCTGCCGGTGTCAAAGCGGGC 
GCCCGCTTTGACACCGGCAGCCACG
CTGGGATG 
pCS2-Wnt3a-S92A CTGCACCACCGTCGCCAACAGCCTGGCC 
GGCCAGGCTGTTGGCGACGGTGGTG
CAG 
pCS2- Wnt3a -N93A GCACCACCGTCAGCGCCAGCCTGGCCATC 
GATGGCCAGGCTGGCGCTGACGGTG
GTGC 
pCS2- Wnt3a A96R GTCAGCAACAGCCTGAGAATCTTTGGCCCTGTT 
AACAGGGCCAAAGATTCTCAGGCTG
TTGCTGAC 
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pCS2- Wnt3a -F169A GTCTCTCGGGAGGCCGCCGATGCCAGG 
CCTGGCATCGGCGGCCTCCCGAGAG
AC 
pCS2- Wnt3a -R173A TTTGCCGATGCCGCCGAGAACCGGCCGG 
CCGGCCGGTTCTCGGCGGCATCGGC
AAA 
pCS2- Wnt3a -N175A GCCGATGCCAGGGAGGCCCGGCCGGATGCCCGC 
GCGGGCATCCGGCCGGGCCTCCCTG
GCATCGGC 
pCS2-Wnt3a-K204A CACCTCAAGTGCGCCTGCCACGGGCTATCT 
AGATAGCCCGTGGCAGGCGCACTTG
AGGTG 
pCS2- Wnt3a -L208A AAATGCCACGGGGCCTCTGGCAGCTGT 
ACAGCTGCCAGAGGCCCCGTGGCAT
TT 
pCS2- Wnt3a -S209A AAATGCCACGGGCTAGCCGGCAGCTGTGAAGTG 
CACTTCACAGCTGCCGGCTAGCCCGT
GGCATTT 
pCS2- Wnt3a -G210R CACGGGCTATCTAGAAGCTGTGAAGTG 
CACTTCACAGCTTCTAGATAGCCCGT
G 
pCS2- Wnt3a -W218A GTGAAGACCTGCGCCTGGTCGCAGCCG 
CGGCTGCGACCAGGCGCAGGTCTTC
AC 
pCS2- Wnt3a -F331A TGCCACTGTGTTGCCCATTGGTGCTGC 
GCAGCACCAATGGGCAACACAGTGG
CA 
pCS2- Wnt3a -W333A CACTGTGTTTTCCATGCCTGCTGCTACGTCAGC 
GCTGACGTAGCAGCAGGCATGGAAA
ACACAGTG 
 
pCS2- Wnt3a -C335A GTTTTCCATTGGTGCGCCTACGTCAGCTGCCAG 
CTGGCAGCTGACGTAGGCGCACCAA
TGGAAAAC 
pCS2- Wnt3a -Y336A 
 
 
TCCATTGGTGCTGCGCCGTCAGCTGC
CAGGA 
TCCTGGCAGCTGACGGCGCAGCACC
AATGGA 
pCS2- Wnt3a -V337A 
 
 
CATTGGTGCTGCTACGCCAGCTGCCA
GGAGTGC 
GCACTCCTGGCAGCTGGCGTAGCAG
CACCAATG 
pCS2- Wnt3a -V337R 
 
 
CATTGGTGCTGCTACAGAAGCTGCCA
GGAGTGC 
GCACTCCTGGCAGCTTCTGTAGCAGC
ACCAATG 
pCS2- Wnt3a -
E68A/F169A 
 
GTCTCTCGGGAGGCCGCCGATGCCA
GG 
CCTGGCATCGGCGGCCTCCCGAGAG
AC 
pCS2- Wnt3a -
K204A/L208A 
 
AAATGCCACGGGGCCTCTGGCAGCT
GT 
ACAGCTGCCAGAGGCCCCGTGGCAT
TT 
pCS2- Wnt3a - 
F331A/W333A 
CACTGTGTTGCCCATGCCTGCTGCTA
CGTCAGC 
GCTGACGTAGCAGCAGGCATGGGCA
ACACAGTG 
 
 
5.1.8 Plasmids  
pCS2+ is a mammalian expression vector and was used as vector for cloning WT 
Wnt3a and mutant constructs. It contains a strong promoter/enhancer region (simian 
CMV IE94), polylinker and SV40 viral polyadenilation signal.  The gene for the WT 
Wnt3a protein was inserted via the restriction site BamHI and NcoI in the mutiple-
cloning site of vector.	  The SP6 viral promoter allows in vitro transcription of sense 
polyadenilated mRNA for microinjections. The T7 viral promoter allows in vitro  
transcription of antisense RNA for in situ hybridization. 
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pCEP-PU-is an episomal mammalian expression vector that uses the 
cytomegalovirus (CMV) immediate early enhancer/promoter for high level 
transcription of recombinant genes inserted into the multiple cloning site. pCEP-PU 
contains the puromycin resistance gene for stable selection in transfected cells. WT 
mouse Wnt3a protein and Wnt3a-Fz8-CRD fusion protein was cloned in this vector 
(Invitrogen). 
 
pFUSE-hIgG3*01-Fc2- is a family of plasmid developed to facilitate the 
construction of Fc-fusion protein by fusing the effector region of a protein to the Fc 
region of an immunoglobulin G (IgG). They contain the IL2 signal sequences (IL2ss) 
for the generation of Fc-Fusion proteins derived from proteins that are not naturally 
secreted. This vector was used to clone mouse Fz8-CRD. They also contain a Zeocin 
resistance gene for stable selection in transfected cells (Invivogen). 
 
 pBluescript- is a phagemid vector usable for DNA cloning. It contains phage f1 
intergenic region required for packaging of DNA into bacteriophage particles 
(Fermentas). 
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5.2 Methods  
5.2.1 Molecular Biology Methods 
5.2.1.1 Polymerase chain reaction (PCR) 
The DNA fragments were amplified by PCR, from a plasmid, which is used as a DNA 
template. The primers contained restriction sites and 3 extra flanking bases at their 3´-
ends. The following composition was used to afford 50 µl sample volume for the PCR 
reaction. 
Table 5: Strandard PCR reaction mixture 
Volume  Components  Stock 
solution 
1 µl Template DNA 20 ng/µl 
10 µl 1X HF buffer 5X 
1.25 µl dNTP 10mM 
4 µl Forward primer  10 pmol/µl 
4 µl Reverse primer  10 pmol/µl 
0.5 µl Preciso rhigh-fidelity polymerase  250U 
 H20  
50 µl Total   
 
The PCR reactions were carried out in the MycyclerTM Thermal cycler from BIO-
RAD (Munich, Germany), using following program. 
 
Table 6: Standard PCR conditions for DNA amplification 
 
 
 
 
 
 
 
 
Step Temperature (0C) Time  
Melting  95 2 min 
Melting  95 30 sec 
Annealing  55-56 30 sec 
Elongation 72 1 min 
Elongation 72 10 min 
Finish 4 ∞ 
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5.2.1.2 Plasmid Construction  
Mouse Wnt3a coding sequences were PCR amplified and cloned into pCS2+ 
expression vector using BamHI and XhoI restriction sites. All point mutations were 
introduced into full-length pCS2-Wnt3a using PCR. All DNA fragments derived from 
PCR were automatically sequenced to confirm the presence of the desired mutation 
and to rule out spurious mutations. The N-terminal domain (1-276) and C-terminal 
domain (277-352) of mouse Wnt3a were cloned into pCS2+ using the same restriction 
sites as above. An expression plasmid encoding the mouse Wnt3a-His was 
constructed by introducing a histidine tag at the C-terminus of Wnt3a in the pCEP-PU 
vector. To generate a C-terminal His-tagged version of mouse NTD and CTD, a 
histidine tag was introduced by PCR-amplification and cloned in pCS2 vector. An 
expression construct for Wnt3a-Fz8-CRD-His fusion protein was generated in the 
pCEP-PU vector (Invitrogen). A short alanine linker was included between C-
terminal Wnt3a fragment and the N-terminal Fz8 CRD lacking the native signal 
sequence. To produce Fz8-CRD-Fc fusion protein, the CRD (i.e. the 135-amino acid 
region extending from the first to the tenth conserved CRD cysteine) was inserted 
between EcoRI and BglII in the pFUSE-hIgG3*01-FC2 vector (InvivoGen, USA), 
which contains an IL-2 signal sequence and a cytomegalovirus immediate-early gene 
1 enhancer and promoter, followed upstream by the hinge region of human IgG heavy 
chain. 
 
5.2.1.3 Site-directed mutagenesis  
In order to create point mutations, site-directed mutagenesis was performed. The 
primers were designed as having the desired mutation site in the middle and amplify 
of the whole vector plus insert. Amplification of plasmid DNA was achieved by 
polymerase chain reaction (PCR). The following composition was used to afford 50 
µl sample volume for the PCR reaction. 
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Table 7:  50 µl Reaction mixer for site directed mutagenesis 
 
Volume  Component Stock solution 
1.0 µl  Template 40 ng/µl 
2.4 µl Sense primer   5 pmol/µl 
2.4 µl Anti-sense primer 5 pmol/µl 
1.2 µl dNTP 10 mM 
1.0 µl Phusion® High-Fidelity DNA 
Polymerase 
2 U/µl 
10  µl Phusion® HF buffer 5 x 
1.0 µl MgCl2 50 mM 
31.5 µl                 Water  
 
The PCR reactions were carried out in the MycyclerTM Thermal cycler from BIO-  
RED (Munich, Germany), using following program 
 
Table 8: PCR program f for site directed mutagenesis 
 
 
 
 
 
 
 
 
•  40 µl of PCR reaction sample was digested with DpnI for 2h at 370 C. This 
enzyme cuts only methylated DNA, so all templates are removed. 
Precipitaton of Dpn I digested product 
• Mix sample (50 µl) with 0.1 volume (e.i 5 µl) of Sodium acetate (3M) and 2.5 
volume (125 µl) of cold ethanol (96%) incubate for 15 min at -20 0 C. 
• Centrifuge at 12000g for 15 min at 4 0 C 
Step Temperature (0C) Time  
Melting  95 2 min 
Melting  95 30 sec 
Annealing  55-56 30 sec 
Elongation 72 1 min 
Elongation 72 10 min 
Finish 4 ∞ 
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• Pellet was washed (transparent) with 70% ethanol  
• Centrifuge at 12000g for 5min.  
• Supernatant was discarded and pellet air-dried. 
• DNA was resuspended in 5 µl H2O 
• 3µl of the digest was transformed into 60µl electro-competent XL1 blue E. 
coli cells and plated on ampicillin agar plates. Incubated overnight at 37˚C. 
 
• Usually, picking 5-6 colonies was enough. All plasmids digested with 
appropriate enzyme to diagnose the presence of the desired mutations, then 
sequenced.  
 
 
5.2.2 Standard DNA manipulation techniques.  
  
5.2.2.1 Digestion with restriction endonucleases.  
 
Cleavage by restriction enzymes (or restriction endonucleases) plays a key role in all 
the gene manipulation procedures. These enzymes, part of the bacterial 
restriction/modification (or restriction/methylation) systems, allow bacteria to monitor 
the origin of incoming DNA and to destroy the molecules recognized as foreign. In 
particular, the enzymes termed type II restriction endonucleases are important in all 
aspects of molecular biology. They recognize specific sequences (usually 4 – 6 bp in 
length) and of specific base composition, and cleave the DNA into fragments in a 
defined manner. The sequences recognized are usually palindromic, that is they read 
the same in both directions on each strand, and when cleaved, they leave a cohesive-
ended fragment. The ends produced from different molecules but by the same enzyme 
are complementary (also ‘cohesive’ or ‘sticky’) and consequently, anneal to each 
other. The standard reaction mixture contained DNA to be cut, the appropriate 
enzyme, enzyme buffer (from 10 × stock) and sterile distilled water. All digests were 
done at 37°C. To double digest pCS2, pCEP-PU vector for cloning PCR products, 5-7 
µg of vector DNA was digested for 5-6 hours in a total reaction volume of 100 µl. 
Both digested vector backbone and PCR products were gel purified after excising 
desired band and used for setting up the ligation reaction.  
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5.2.2.2 Dephosphorylation.  
To reduce the background in cloning experiments, phosphatases which remove the 5’-
terminal phosphate groups from a nucleic acid strand are used. By dephosphorylating 
the restricted cloning vector they prevent its re-ligation, eliminating any possibility of 
dimer formation or re-circularization of the vector.  The restricted, linearized vector 
DNA was treated with calf intestine alkaline phosphatase before ligation. For 
dephosphorylation of restricted vector, 1-3 µg of DNA was treated with 0.25-0.5 units 
of enzyme for 30 min at 37°C in the final volume of 50 µl.  
 
5.2.2.3 Ligation  
 
The cohesive ends produced by certain restriction enzymes anneal and can be joined 
covalently by DNA ligase to create artificially recombinant molecules. The ligase 
forms a covalent bond between the 5’-phosphate at the end of one strand and the 3’-
hydroxyl of the adjacent one. Ligation of the specific DNA fragment with a 
specialized DNA carrier molecule (vector) is necessary in order to be able to 
propagate the DNA of interest. Ligation was performed using T4 DNA ligase  
(Promega) as recommended in the manufacturers instructions. Briefly, 1 µl (5 units) 
of T4 DNA ligase was used and the vector/insert ratio of 1:5 for all constructs (total 
DNA about 50 ng) in a final volume of 10 µl was used.  A control ligation reaction 
with vector but no insert DNA present was set up at the same time to assess the 
likelihood of vector re-ligation (reaction background). The ligation was performed 
either for 2-3 hours at 370C or overnight at 160C.  The ligated fragments were then 
transformed into E.coli XL1 blue strain.  
 
 5.2.2.4 Transformation of electrocompetent bacteria 
 
One aliquot of electrocompetent cells was thawed on ice and mixed gently with 1 ng - 
200 ng of plasmid DNA. The DNA and cells were transferred to a prechilled 
electroporation cuvette. An electric pulse (25 µF, 2.5 kV, 200, field strength: about 
12,5 kV/cm) was applied. Usually a time constant of 4.8 - 5.2 ms indicated that the 
procedure was successful. After transformation, the bacteria were mixed with 1 ml 
SOC-medium immediately and incubated at 37 0C in a shaker for 30 - 60 minutes. 
Different volumes of cells were either plated on LB-plates or the cells were directly 
used to inoculate a liquid culture.  
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The appropriate antibiotics were added to the medium or plates to select for the 
desired transformants. 
 
5.2.2.5 Transformation of chemocompetent bacteria 
 
The chemocompetent cells were thawed rapidly and mixed gently with up to 200 ng 
of plasmid DNA. The DNA and cells were cooled on ice for 15 min. The cells were 
heat shocked for 50 seconds at 42 0C. After transformation, the bacteria were chilled 
on ice for 2 minutes and mixed with 1 ml SOC-medium. The bacteria were incubated 
at 37 0C in a shaker for 30 - 60 min. Different volumes of cells were either plated on 
LB-plates or the cells were directly used to inoculate a liquid culture. The appropriate 
antibiotics were added to the medium or plates to select for the desired transformants. 
 
5.2.2.6 Purification	  of	  plasmid	  DNA	  
	  
DNA has been amplified in bacteria as ‘high copy’ (300  >1000 copies per cell) or 
‘low copy’ (5-20 copies per cell) extrachromosomal plasmid DNA. The plasmid DNA 
was isolated by alkaline lysis. The bacteria were lysed by the addition of sodium 
hydroxide. The cell membranes were dissolved and the proteins denatured. 
Neutralization led to precipitation of the denatured proteins and bacterial 
chromosomal DNA. The plasmid DNA, which stayed in solution, was isolated. 
For the purification of plasmid DNA in a small scale, the Wizard Plus SV Minipreps 
DNA Purification System from Promega was used according to the manufacturer´s 
instructions. 
For the purification of plasmid DNA on large scale, Qiagen Midi prep DNA 
purification system was used according to the manufacturer’s instructions. 
 
 
 5.2.2.7 Extraction of nucleic acids by phenol-chloroform 
 
The phenol-chloroform extraction method is used to remove proteins from nucleic 
acids solutions. Proteins are denatured by phenol and accumulate in the organic phase 
and at the interphase between the organic and the aqueous phase. Chloroform helps to 
separate the two phases and isoamyl alcohol prevents the formation of foam. An 
equivalent volume of phenol-chloroform-isoamyl alcohol (25:24:1) was added to the 
DNA solution.  
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The solutions were vigorously mixed by shaking for 1 minute. The organic and the 
aqueous phase were separated by centrifugation at top speed in a tabletop centrifuge 
for 5 minutes at room temperature. The upper, aqueous phase was transferred to a 
new tube and an equal volume of chloroform-isoamyl alcohol (24:1) was added. 
Again the solutions were mixed by shaking and the phases were separated by 
centrifugation. The aqueous phase contains the nucleic acids. 
 
5.2.2.8 Precipitation of DNA 
 
Ethanol precipitation was used to purify and concentrate DNA from aqueous 
solutions. A mixture of salt and ethanol forces the DNA to precipitate out of solution 
by decreasing its solubility in water. To an aqueous solution of DNA 1/10 volume of 
3 M sodium acetate (pH 5.2) and 2.5 volumes of 100% ethanol were added. The DNA 
was centrifuged at top speed in a tabletop centrifuge for 20 minutes at room 
temperature. The pellet was washed with 70% ethanol. Finally the pellet was air-dried 
and dissolved in an appropriate amount of H2O or TE-buffer. 
 
5.2.2.9 Quantification of DNA 
 
The concentration of DNA was determined by spectrophotometry using the Nanodrop 
spectrophotometer from Peqlab. 1-2 µl of DNA was used for analysis at absorption of 
260 nm. An OD260 of 1.0 equals a DNA concentration of 50 µg DNA per ml. (For 
RNA, an OD260 of 1.0 equals an RNA concentration of 40 µg RNA per ml) 
Conclusions on the purity of the DNA were made by examining the ratio of OD260 to 
OD280. A value between 1.8 and 2.0 represents a high-quality DNA sample. 
 
5.2.2.10 Analysis of DNA by gel electrophoresis: agarose gel electrophoresis 
(AGE) 
 
The quality and size of DNA was analyzed by agarose gel electrophoresis. Plasmid 
DNA preparations and PCR reactions were analyzed on 1% agarose gels using 1 x  
TAE. To check the size of the DNA, additionally a DNA size marker has been loaded 
onto the gel. Electrophoresis was carried out at 100 mV in the same buffer, which was 
used for the preparation of the gel. The DNA was visualized by staining for 10 
minutes in an ethidium bromide solution and detection at 254nm using a 
transilluminator.  
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The gels were documented using the INTAS gel documentation system.  
  
5.2.3 Preparation of mRNA for embryos injection  
Capped mRNAs for injections were prepared from linearized template using the 
mESSAGE mACHINE® SP6 in vitro transcription kit (Ambion)  
Linearization of DNA template 
• Plasmids (pCS2+) encoding the DNA template were linearized with restriction 
enzyme NotI (NEB) for 5-6 hours.  
• Linearized plasmids were purified by adding equal volume of buffer saturated 
Phenol:chlorophorm:Isoamyl alcohol (1:1). And further traces of phenol were 
removed by adding equal volume of chlorophorm to the aqueous layer. 
• After chloroform extraction upper phase was precipitated with 1/10 of Na- 
            acetate and 2.5 volume of cold absolute ethanol was mixed at RT for 30     
            min. 
• Precipitate was pelleted at max. speed for 15 min, washed with 75% ethanol, 
dried and resuspended in 15 µL nuclease free water.  
 
RNA synthesis by in vitro transcription  
• The RNA Polymerase Enzyme mix  was  placed on ice, vortexing of  the 10X 
reaction buffer and the 2X NTP/CAP was done till they are completely in 
soultion (RT). Once thawed, store the ribo-nucleotide (2X NTP/CAP) was 
placed on ice, but 10X reaction buffer was kept at room temperature while 
assembling the reaction. 
•  Transcription reaction was assembled  at room temperature because the 
spermidine in the 10X reaction buffer could coprecipitate the template DNA if 
the reaction was  assemled on ice. The 10X reaction buffer was added after the 
water and the ribonucleotide was already in the tube. 
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                            Table 9: 20 µ l transcription reaction  
 
Linear DNA template  2-4 µl 
2XNTP/CAP 10 µl 
10X Reaction buffer 2 µl 
Enzyme mix  2 µl 
Nuclease free water  to 20 µl 
 
• Samples were incubated at 37 0C for 3-5 hours, and subsequently  treated     
with  1 µl DNase I at at 37 0C for 15 minutes. 
Purification of RNA transcripts  
• To stop the reaction 125µl Nuclease- free water and 15 µl Ammonium acatate  
were added to samples, and mixed throroughly. 
• Samples were extracted with an equal volume of Phenol/ Chloroform and then 
with an equal volume of Chloroform. The aqueous phase was removed and  
transferred to a new tube. 
• RNA was precipitated  by adding 1 volume of Isopropanol. Samples were kept 
least 30 min at -20°C.  
• Precipitates were pelleted  at 4°C for 30 min at 15000 rpm.  
• The supernatant was removed with a pipette, and the pellets were washed once 
with 70% ethanol and dried briefly  
• Dried pellets were dissolved in 20 µl nuclease free water, concentrations were 
quantified photometrically, and RNA quality was checked on an 1% agarose 
gel.  
 
5.3 Embryological Methods  
5.3.1 Xenopus laevis stem culture  
Adult wild type specimens of Xenopus laevis were obtained from Xenopus Express 
(Le Bourg 43270, France). They were kept in groups of 20 to 30 animals in tap water 
at 19°C and fed 2-3 times a week with chopped beef heart or pellets (special clawed  
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frog food, Provimi Klima, Switzerland). 
 
5.3.2 In vitro fertilization of Xenopus laevis oocytes  
Adult Xenopus laevis males were sacrificed to surgically remove their testes, which 
were then stored at 4°C in testis buffer (80% MMR, 20% fetal bovine serum (FBS), 
and 50 µg/ml Gentamycin). Adult Xenopus laevis females were stimulated to start 
oogenesis by hypodermal injection of 500 IU of human chorionic gonadotropin (hCG, 
Sigma-Aldrich) the evening before microinjection. Oocytes were collected the next 
day by gently squeezing the animals. Xenopus sperm suspension was prepared by 
macerating a small piece of testis in 1 ml of 1X MBS-H (88 mM NaCl, 1 mM KCl, 
2.4 mM Na2HCO3, 0.82 mM MgSO4, 0.33 mM Na(NO3)2, 0.41 mM CaCl2, 10 mM 
HEPES pH 7.4, 10 µg/ml Streptomycin sulfate, and 10 µg/ml Penicillin). Oocytes 
were fertilized with 400 µl of sperm suspension and covered with deionized water. 
Fertilization was successful when eggs reoriented in relation to gravity with their 
pigmented animal pole facing upwards. Embryos were dejellied by treatment with 2% 
Cysteine (pH 8) for 3-4 minutes followed by several washing steps with deionized 
water, and were then transferred to 1X MBS-H.   
 
5.3.3 Zebrafish maintenance and stages of embryonic development  
 
Zebrafish embryos (Danio rerio) were obtained from the fish facility of Centre for 
organismal studies (COS). The fish were maintained according to the method described 
by Westerfield (Westerfield, 1995). Zebrafish AB wild-type line was staged as 
described previously (Kimmel et al, 1995). 
            
Table 10. List of constructs for mRNA injection in Xenopus embryos 
 
Plasmids  Linearization  Transcription  Source  
pSC2-mWnt3a NotI SP6 This study  
pSC2-mWnt3a-NTD NotI SP6 This study  
pSC2-mWnt3a-CTD NotI SP6 This study  
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Table 11. List of constructs for mRNA injection in zebrafish embryos 
 
Plasmids  Linearization  Transcription  Source  
 
pSC2-mWnt3a NotI SP6 This study  
pSC2-mWnt3a-V60R NotI SP6 This study  
pSC2-mWnt3a-E68A NotI SP6 This study  
pSC2-mWnt3a-F169A NotI SP6 This study  
pSC2-mWnt3a-S209A NotI SP6 This study  
pSC2-mWnt3a-G210R NotI SP6 This study  
pSC2-mWnt3a-F331A NotI SP6 This study  
pSC2-mWnt3a-W333A NotI SP6 This study  
pSC2-mWnt3a-C335A NotI SP6 This study  
pSC2-mWnt3a-V337R NotI SP6 This study  
pSC2-mWnt3a-E68A/F169A NotI SP6 This study  
pSC2-mWnt3a- 
F331A/W333A 
NotI SP6 This study  
 
 
5.3.4 mRNA microinjections in frog (Xenopus) and zebrafish (Danio rerio) 
Embryos 
 
Capped mRNAs coding for wild type mWnt3a, NTD and CTD were synthesized from 
linearized pCS2+ plasmids using the mESSAGE mACHINE Kit (Ambion). Embryos 
for the axis duplication assay were injected at the ventral marginal zone at 4 cell-stage 
with the 3, 30, 300 pg of indicated mRNAs and screened for axis-duplication after 48 
hours with an Olympus SZX12 stereomicroscope and a Soft Imaging System CC-12 
digital camera. 
Zebrafish AB wild-type line were raised and staged as described previously (Kimmel 
et al, 1995). For zebrafish injection experiments, a series of 1.5, 3, 33, 100 and 300pg 
of wild type mWnt3a mRNA was first injected and dose dependence evaluated. 3 pg 
of mWnt3a or more, caused very severe abnormalities at 1dpf, therefore 2 pg of each 
mRNA was microinjected into 1-cell stage embryos in experiments. Embryos were 
incubated in E3 medium (with additional PTU after 20hpf) at 28 °C and examined at 
1, 1.5 and 3dpf. Zebrafish embryos were either photographed live or fixed with 4% 
PFA and stained with Alexa-488 conjugated Phalloidin (Molecular Probes), mounted 
in 1% low melting point agarose and imaged on A1R (Nikon) confocal microscope 
using 40x LWD water immersion objective. 
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5.4 Cell Culture Methods  
5.4.1 Maintaining cells in culture  
Human embryonic kidney 293T cells and mouse L-cells were routinely maintained in 
Dulbecco’s modified Eagle’s medium, containing 10% fetal bovine serum and 1% 
penicillin/streptomycin in 5% CO2 at 37 0C. The media for LWnt3a cells were also 
supplemented with 0.4mg/ml G418 (Invitrogen). In order to replenish nutrients and 
avoid the potentially harmful metabolic by products and dead cells, the cells were 
passaged every 2 or 3 days according to the confluency of the cells.  
Table 12: List of Cell culture media and solutions obtained from PAA if       
mentioned otherwise. 
 
Product Ingredients and Usage 
DMEM with L-Glutamine  Glucose (4.5 g/l) with L-Glutamin for cell 
cultivation  
DMSO   Cell cryopresenvation 
FCS, Fetal calf serum Additive for cell culture medium 
Pencillin-Steptomycin antibiotic solution 10,000 U/ml Pencillin and 10mg/ml 
Streptomycin as an antibacterial in cell 
culture medium 
G 418 (Invitrogen) Maintaining LWnt3a cells  
Trypsin EDTA solution  0.05% trypsin/ and 0.02% EDTA, for cell 
passage 
jetPRIMETM  (Polyplus) Cell transfection 
Advanced low serum DMEM/F-12 For protein expression  
 
5.4.2 Passaging of the cells  
 
In order to passage the cells, the medium was aspirated and the adherent cells were 
gently washed once by 10 ml of 1X PBS. PBS was then aspirated and 2 ml of 0.05% 
trypsin/0.02% EDTA was added onto cells and distributed all over the plate for the 
detachment of the cells from the plate. The Trypsin-EDTA was aspirated and the cells 
were incubated in 37°C incubator for 5-10 minutes. A 10 ml of appropriate medium  
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was added onto cells to resuspend and collect the cells. For continuation of the cells in 
culture, 1/10 dilution was done.  
5.4.3 Freezing and thawing of the cells 
For freezing, the cells were harvested at 1000 rpm for 2 minutes and washed once 
with 1X PBS. After removal of the PBS, the cells were resuspended in freezing 
medium, which contains 10% DMSO and 90% of serum. DMSO was used as a 
cryoprotectant to protect the cells from rupture by the formation of ice crystal.  1 ml 
of the suspension was added into each cryo-tube. In general, from one 10 cm dish 
with 80% confluency, 2 ml of cell suspension was generated. The tubes containing the 
cells were then placed in -80°C freezer overnight. For longer storage, the cells were 
transferred to the liquid nitrogen tanks. For thawing, the cells taken from liquid 
nitrogen were placed into 37°C water bath. In order to avoid the toxic effect of 
DMSO, this process should be performed quickly. As soon as the cells were thawn, 
they were transferred into 15 ml falcon tubes containing the appropriate medium. In 
order to get rid of residual DMSO, the cells were washed with the medium for two 
times. After the last wash, they were resuspended in medium and transferred into 10 
cm dishes and placed in 37°C incubator.  
5.4.4 Transient transfection of cells  
Cells were split one day prior to transient transfection and grown to 60-70% 
confluence. The HEK293T cells were transfected using jetPRIMETM reagent 
(Polyplus transfection, USA) according to the manufacturer’s protocol. After 
transfection, cells were kept in DMEM and harvested after 24-48 hours, depending on 
the experiment.       
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Table 13: Transfection of HEK293T cells with jetPRIMETM 
 
Culture 
Vessel 
Volume of 
jetPRIME® 
Buffer (µ l) 
Amount of 
DNA 
(µg) 
Volume of 
jetPRIME® 
reagent (µl) 
 
Volume of 
growth 
medium 
(ml) 
24-well 50 0.5 1 0.5 
12-well 100 1 2 1 
6- well 200 2 4 2 
Flask 75cm2 500 10 20 10 
 
Table 14: List of constructs used for transfection of HEK293T cells 
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5.5 Dual luciferase reporter gene assay  
Luciferase reporter assays were carried out in HEK293T cells in 384 well plates. 
HEK 293T cells were seeded 24 hours prior to transfection. Cells were transiently 
transfected with the reporter construct TCF-firefly (10ng), actin- Renilla (10ng) and 
Wnt3a (5ng) or mutant isoforms, and balanced with empty expression vector (pRL-
CMV) using TransIT (Mirus Bio LLC, USA) according to the manufacturer’s 
protocol. Firefly luciferase and Renilla luciferase activities were measured using the 
dual luciferase assay kit (Promega, USA) and detected using a Mithras LB940 
Multimode Microplate Reader Luminometer (Berthold Technologies, Germany). 
Renilla luciferase activity was measured as an internal control for transfection   
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efficiency. The Wnt-induced relative luciferase activity is depicted as the ratio of the 
activity of the firefly to Renilla luciferase. All assays were performed in triplicate and 
repeated in independent experiments. 
5.5.1 Peptide library generation and epitopes screening  
Peptides covering the complete mouse Wnt3a sequence with a 5 amino acid overlap 
were synthesized by Eurogentec (Seraing, Belgium) using standard solid-phase Fmoc 
chemistry. All peptides were analyzed by Reverse phase HPLC (RP-HPLC) for purity 
assessment. Molecular masses of all peptides were confirmed by MALDI Mass 
Spectrometry. Binding epitope screening was done using a double luciferase Wnt 
reporter assay. The HEK293T cells were seeded in a 384-well plate 24 hours prior to 
transfection. Cells were transiently transfected with reporter construct TCF/Firefly, 
actin-Renilla luciferase and wild type Wnt3a construct using TransIT (Mirus Bio 
LLC, USA) according to the manufacturer’s protocol. After 24 hours of transfection 
peptides were added at a final concentration of 1µM. After 24 hours firefly luciferase 
(Wnt reporter) activity and Renilla luciferase activity were measured according to the 
manufacturer’s protocol (Promega, USA). For assaying possible agonistic effects of 
the peptides transfection of the Wnt3a construct was omitted. The peptide 
concentration of 1µM was chosen to have an optimal readout of antagonistic effects 
without toxic effects on the cells. 
 
5.6 Biochemical methods  
5.6.1 SDS-PAGE 
SDS-PAGE (sodium dodecyl sulfate polyacrylamide gel electrophoresis) is a 
technique, which is used to separate proteins by size in a discontinuous gel system 
under denaturing conditions. Due to binding of SDS, the proteins are charged 
identically in proportion to their mass. The proteins are negatively charged and 
migrate to the anode during electrophoresis. For protein separation, 12% resolving 
gels and 6% stacking gels have been cast between two glass plates. After 
polymerization, the protein samples and a prestained molecular weight marker 
‘PageRuler Prestained Protein Ladder’ from Fermentas or ’Prestained Protein Ladder,  
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Broad Range’ from NEB) have been loaded onto the gel. The molecular weight 
marker was used to monitor the progress of the electrophoretic run and to calculate 
the molecular weights of the samples. 
 
Table 15: Solution mixture for polyacrylamide gel preparation 
 
Components Separating Gels (16 ml) 
12% 
(Stacking gel (10 ml) 
6% 
dH2O 6.9 ml 5.6 ml 
40% Acrylamide  4.8 ml 1.5 ml 
1.5 M Tris pH 8.8 4 ml - 
0.5 M Tris pH 6.8  2.5 ml 
10% SDS 160 µl 100 µl 
10% APS 160 µl 100 µl 
TEMED 16 µl 10 µl 
 
Protein samples for SDS-PAGE were prepared by addition of 5X sample buffer (10% 
w/v SDS, 300 mM DTT, 20% v/v glycerol, 0.2 M Tris-HCl, pH 6.8, and 0.05% 
bromophenol blue) and heating at 95°C for 5 min. Samples were electrophoretically 
separated on a 12% polyacrylamide gel. Electrophoresis was done in 1X running 
buffer (25 mM Tris, 200 mM glycine, and 0.1% (w/v) SDS) at a constant current of 
20 mA using the Mini Protean 3 system (Bio-Rad). Afterwards, gels were stained 
with Coomassie brilliant blue R-250 or used for western blotting. 
 
5.6.2 Western blotting (semi-dry)  
Proteins were transferred from polyacrylamide gels to a PVDF transfer membrane 
(Immobilon™-P, Millipore). Membranes were activated in 100% Methanol for 15 
seconds and washed in deionized H2O for 1 min. Polyacrylamide gels, activated 
membranes, and 6 sheets of Whatman® chromatography paper were equilibrated in 
1X blotting buffer (25 mM Tris, 150 mM glycine, and 10% (v/v) methanol) and 
assembled in a Bio-Rad Trans-Blot SD semi-dry transfer cell. Transfer was done at a 
constant voltage of 12V for 1 hour using a Bio-Rad PowerPac™ HC power supply.  
Afterwards, membranes were blocked in 5% BSA/PBS Tween 0.2% for 1 hour  
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followed by incubation with primary antibody diluted 1:1000 in 1% BSA/PBS Tween  
0.2% over night at 4°C on a rotator. The next day, membranes were washed 3x 5 min 
in PBS Tween 0.2% and incubated with peroxidase-conjugated secondary antibody in 
5% BSA /PBS 0.2% Tween for 1 hour at room temperature. Finally, membranes were 
washed 3x 10 min with PBS 0.2% Tween and 2x 10 min with PBS. To detect the 
proteins by chemiluminescence, membranes were incubated for 1 min in a 1:1 
mixture of ECL solution 1 (2.5 ml of 1M Tris pH 8.5, 200 µl of luminol, and 88 µl of 
cumaric acid to a final volume of 20 ml) and ECL solution 2 (2ml of 1 M Tris pH 8.5 
and 12 µl of H2O2 to final volume of 20 ml). In a darkroom, an autoradiographic film 
(Amersham Hyperfilm ECL, GE Healthcare) was exposed to the membranes for 
different time point and developed in a Curix 60 processor (Agfa). 
 
5.6.3. BCA protein assay for peptides concentration determination  
The Protein concentration of Wnt3a synthetic peptides was determined according to 
standard protocol of Pierce™ BCA Protein Assay Kit (Thermo Scientific). BCA 
Protein Assay is a detergent-compatible formulation based on bicinchoninic acid 
(BCA) for the colorimetric detection and quantization of total protein. This method 
combines the well-known reduction of Cu+2 to Cu+1 by protein in an alkaline medium 
(the biuret reaction) with the highly sensitive and selective colorimetric detection of 
the cuprous cation (Cu+1) using a unique reagent containing bicinchoninic acid. The 
purple-colored reaction product of this assay is formed by the chelation of two 
molecules of BCA with one cuprous ion. This water-soluble complex exhibits a 
strong absorbance at 562nm that is nearly linear with increasing protein 
concentrations over a broad working range (20-2000µg/mL). For each measurement a 
complete calibration curve with BSA-standards raining from 20-2000 µg/ml protein 
has been generated. The BSA standards for calibration were measured in triplicate. 
For the determination of the peptide concentration, a total of 10 µl sample mixed with 
200 µl working reagent (WR). Samples were incubated for 30 min at 370C in water 
bath, further cooled to room temperature. The absorption of sample was determined at 
562 nm using BCA program in nanodrop.   
 
5.6.4 OD280 measurement 
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The protein concentration of purified proteins and cell extracts was determined by 
measuring the absorbance at 280 nm in a spectrophotometer versus a suitable control. 
An absorbance of 1.0 at 280 nm equates a protein concentration of 1 mg/ml. This 
method provides a rough approximation of the protein concentration. 
 
5.6.5 Rapid Coomassie staining 
 
The dye Coomassie Brilliant Blue binds unspecifically to proteins and can be used to 
stain proteins (Wilson, 1983). For staining of proteins in polyacrylamide gels, the 
rapid Coomassie staining described by Sasse and Gallagher (2009) has been used. 
After SDS-PAGE, the polyacrylamide gel was soaked in fixation solution (25% 
isopropanol, 10% acetic acid) and incubated for 30 minutes at room temperature. The 
gel was transferred to the staining solution (10% acetic acid, 0.006% Coomassie 
Brilliant Blue G-250), and staining was performed until distinct protein bands became 
clearly visible on the gel. The gel was documented using the INTAS gel doc system. 
 
5.6.6 Preparation of total protein lysate  
To detect Wnt3a proteins in cell lysates, HEK 293T cells were transfected with wild 
type Wnt3a or its mutant isoforms. The cells were harvested after 48 hours of 
transfection, washed with ice cold 1X PBS and disrupted in lysis buffer [20 mM Tris 
(pH 7.5), 150 mM NaCl, 1% NP-40, 10 mM EDTA protease inhibitor cocktail 
complete (Roche)]. The resulting supernatant was transferred to a fresh tube. Proteins 
were analyzed by Western blot using anti-Wnt3a antibody. For loading control the 
membranes were probed with anti-α-tubulin. 
5.6.7 Production of mouse Wnt3a and mutant isoforms in HEK293T cells 
To collect conditioned medium of wild type mouse Wnt3a and indicated mutants, 
HEK293T cells were transiently transfected with the corresponding cDNAs under 
control of a cytomegalovirus immediate early gene enhancer and promoter. For 
protein expression, cells were incubated at 37 °C for 48 hours in DMEM containing 
10% fetal bovine serum and 1% penicillin/streptomycin. Then conditioned media 
were harvested, centrifuged at 2000 g for 10 min, and directly used or stored in  
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aliquots at -80 0C. Control medium was prepared from untransfected HEK 293T cells 
following the same protocol. For the solution-binding assay conditioned media 
containing wild type Wnt3a or mutant isoforms were produced in low serum (3% 
FBS) condition. To detect the secretion levels of wild type Wnt3a and mutant 
isoforms, equal amounts of conditioned media were resolved on 12% SDS-PAGE and 
analyzed by Western blot using anti-Wnt3a antibody.  
For production of pCS2-Wnt3a-NTD-his, pCS2-Wnt3a-CTD-his, pCEP-Pu-Wnt3a-
His and pCEP-Pu-Wnt3a-Fz8-CRD-his conditioned medium, HEK 293T cells were 
transiently transfected with 10 µg of the respective plasmids in 75-cm2 flasks. One 
day after transfection, cells were transferred to advanced low serum DMEM/F-12 
(GIBCO, Invitrogen) and secreted proteins were harvested after additional 48 hours.  
Proteins were in addition purified by incubating conditioned medium with Ni-NTA 
agarose beads (Qiagen) for 1 hour at 40C.  Bound proteins were eluted with elution 
buffer (300 mM Imidazole pH 8.0, 250 mM NaCl, 1X PBS). Purified proteins were 
resolved on 12% SDS-PAGE and analyzed by western blotting using anti-his 
antibody. 
5.6.8 Production and purification of Fz8-CRD-Fc fusion protein from HEK 293T 
cells  
The mouse Fz8-CRD-Fc and Fc were produced in HEK293T cells that were 
transiently transfected by using jetPRIMETM reagent (Polyplus transfection, USA). 
One day after transfection, cells were transferred to advanced low serum DMEM/F-12 
(GIBCO, Invitrogen corporation), and secreted protein was harvested after additional 
48 hours. Control conditioned medium was obtained from untransfected 293T cells. 
For purification of Fz8-CRD-Fc and Fc conditioned medium was incubated with 
Protein G Agarose (Roche Diagnostics GmbH, Mannheim, Germany) for 3 hours at 
40C, and washed three times with wash buffer (10 mM Tris-Cl pH 7.8, 0.2 mM 
EDTA, 250 mM NaCl, 0.1% Tween). Proteins were eluted in low pH elution buffer 
(0.1 M Glycine-HCl pH 2.5, 0.1 %Tween) and immediately neutralize with 1 M Tris-
HCl, pH 9.0). Purified protein was resolved on SDS-PAGE and analyzed by Western 
blot and Coomassie blue staining. 
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5.6.9 Solution binding Assay  
To investigate the binding of Wnt3a mutants with Fz8-CRD-Fc we used solution-
binding assay. Twelve micrograms of recombinant mouse Fz8-CRD-Fc or Fc alone as 
negative control were pre-incubated with Protein G Agarose (Roche Diagnostics 
GmbH, Mannheim, Germany) for 3 hours at 4°C, then beads were washed with 2 
times with cold 0.01% Triton X-100, 1X PBS, and two times with cold 1X PBS. The 
beads were then incubated with 1 ml of Wnt3a conditioned medium for 3-4 hours. 
The beads were separated by centrifugation and washed 4 times with cold 0.01% 
Triton X-100, 1X PBS buffer and boiled in 2X SDS sample buffer containing beta-
mercaptoethanol. The supernatants were analyzed by Western blot analysis using anti-
Wnt3a primary antibody. The membranes were further re-probed with anti-human 
IgG antibody for loading control of Fz8-CRD-Fc and Fc. 
5.6.10 Modulation of Wnt3a activity and solubility by soluble CRD protein 
 
To investigate the effect of recombinant Fz8-CRD protein on Wnt solubility, 
HEK293T cells were transfected with wild type 1 µg Wnt3a plasmid in 24 well plates 
and cultivated in 500 µl DMEM medium supplemented with 10% FCS. After 24 
hours the indicated amount of recombinant Fz8-CRD-Fc or Fc alone as negative 
control was added on Wnt3a producing cells and further incubated for 16-20 hours. 
Supernatant containing Wnt3a protein was analyzed by Western blot using the anti-
Wnt3a antibody. For dual chamber luciferase assay HEK293T cells were seeded on 
thinCerts TC chambers with a pore size of 8.0 µm (Greiner, Germany), transfected 
with 0.25µg CMV-b-Galactosidase and 0.4 µg Super TOPFlash by Ca++-phosphate 
precipitation and cultivated in 1 ml DMEM medium supplemented with 10 % FCS. 
40 hours before analysis, the inlets with the transfected cells were transferred on 
mouse Wnt3a producing cells (ATCC: CRL-2647) seeded in 500µl DMEM medium 
supplemented with 10 % FCS in 12 well plates. The recombinant Fz8-CRD protein 
was added 16 hours before analysis to the Wnt producing cells and relative luciferase 
activity was measured.  
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5.7 Bioinformatics  
5.7.1 Modeling of Wnt3a structure 
 
We performed a homology modeling based on the most recently determined crystal 
structure of the XWnt8-Fz8-CD complex (Janda et al, 2012) (pdb-code: 4F0A). Both,  
ligand and receptor gather homology scores of >75%. For subsequent modeling steps, 
two criteria’s were important: the e-value as returned by BLASTP against PDB 
dataset and the 3D-Jury score from the metaserver which represents an approximation 
to the number of Ca atoms within 3.5Å from the PDB template as compared to the 
current theoretical model. Since the secondary structure coverage of the PDB 
corresponded to the secondary structure elements predicted for Wnt3A by PSIPRED, 
DSSP, STRIDE, and PROFSEC, it seemed reasonable to try a homology modeling 
protocol to the PDB from XWnt8-Fz8-CRD as templates using alignment information 
provided by the metaserver. Modeller9v2's (http://salilab.org/modeller/) script for 
automated model generation using homology modeling was run with successive 
molecular dynamics simulated annealing refinement (refine.slow) and repeated 
optimization (4 times) to get the first impression of the model. Finally, the model was 
optimized with variable target function method (VTFM), which tries to minimize 
constraint violations (e.g. torsion angles) with a maximum of 300 iterations. 
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6. Results 
6.1 Identification of binding epitopes in mouse Wnt3a for Fz    
receptor engagement   
    
Wnt ligands bind to Fz receptors and activate the Wnt/β-catenin signaling pathway. 
However, it is unknown which epitopes of Wnt bind to Fz. To gain insight on this 
issue, an unbiased screen was performed to identify the binding epitopes in mouse 
Wnt3a protein that are significant for signaling via receptor (Frizzled) binding. I have 
designed a peptide library covering the complete sequence of the mature mouse 
Wnt3a protein. The 33 different peptides comprised a length of 15 amino acids with a 
5-residue overlap were synthesized (Fig. 6A). All peptides were screened for their 
biological activity in a Wnt reporter assay. HEK 293T cells were transiently co-
transfected with the reporter construct TCF/firefly, actin-Renilla luciferase in 
presence and absence of wild type Wnt3a.  The Peptides were added to the cells at 
1µM concentration (Fig. 6B).      
 
From the Wnt reporter assay it was found that peptides from the N-terminal half of 
the Wnt3a sequence (1-14, residues 1-163) reduced signaling by Wnt3a only 
moderately (Fig. 6C), indicating a minor contribution of this region to signaling. 
Peptides 19 and 20, which harbor the lipid attachment site Ser209 (site 1) reduced the 
relative luciferase activity by up to 70% as compared to Wnt3a alone. A significant 
reduction of reporter activity was also observed for peptides 22-27, which harbor 
predicted LRP5/6 binding sites. From the site 2 containing peptides only peptide 31 
showed a pronounced inhibitory effect, although peptide 32 contained the complete 
set of site 2 residues. This might be due to the formation of non-native disulfide bonds 
in peptide 32. Interestingly we observed that none of the applied peptides showed an 
agonistic effect in the absence of full-length Wnt3a (Fig. 6C, red columns) suggesting 
a synergistic contribution of the binding sites to effective signaling. It was found 1µM 
peptide concentration optimal for this peptide screen without having any toxic effect 
on cells.  
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Fig.6. Identification of binding epitopes in mouse Wnt3a for Fz binding (A) Library of 33 
synthetic linear peptides covering the whole mouse Wnt3a sequence. Each peptide was 
designed to have a length of 15 amino acids with a 5-residue overlap. (B) Workflow of 
peptide screen done in HEK 293T cells for Wnt reporter assay (C) Binding screen of peptides 
at 1µM was performed using a standard Wnt reporter assay in HEK293T cells in the presence 
(black column) or the absence (red column) of mouse Wnt3a. Peptides encompassing site 1, 2 
or 3 residues are marked accordingly. Peptides harboring potential binding sites for LRP5/6, 
Ryk and Ror2 co-receptors are marked with asterisks. LRP5/6 binding sites according to (Chu 
et al, 2013) are marked with green triangles. 
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6.2 Structure analysis of mouse Wnt3a protein   
 
In order to predict the critical sites in mouse Wnt3a required for Fz8-CRD binding, I 
have generated a structural model on the mouse Wnt3a-Fz8-CRD complex (Fig. 2B) 
adopting the recently published X-ray structure of Xenopus Wnt8 complex with Fz8-
CRD (Janda et al, 2012). Mouse Wnt3a protein has 83% sequence identity with 
XWnt8 (Fig. 7A). The overall structure of Wnt3a in complex with Fz8-CRD is similar 
to a hand with a thumb and an index finger projecting from a central palm domain to 
interact with the Fz8-CRD at two distinct binding sites within the N-terminal and C-
terminal domains designated as site 1 and site 2 respectively (Table 17). The N-
terminal domain is primarily a α-helix bundle structure with two β-strands hairpin 
extensions packed against each other. The site 1 interaction is dominated by the lipid 
group attached to a conserved serine 209 (S209) at the tip of the thumb, which is 
directly involved in binding to Fz8-CRD.  Sites 2 is located at the conserved 
hydrophobic loop (C329-V337) in the CTD of Wnt3a and interact with Fz8-CRD via 
highly conserved residues (Appendix 9.2). Some of the contact points on the Fz8-
CRD are substituted in other Fz-CRDs, thus providing a possible mechanism to 
influence Wnt-Fz binding specificities.  
 
Another potential interaction was observed in the crystal structure at pseudo-site 3. 
The residues involved in this interaction were poorly conserved among the different 
Wnt proteins (Appendix 9.2) but residues on the Fz8-CRD contacting Wnt3a in this 
site are mostly conserved.  Pseudo-site 3 mediates formation of asymmetric Wnt/Fz 
dimer in the crystal and can generate a repeating oligomer, it may account for Wnt-
induced receptor clustering and signalosome assembly. 
 
However, it is remained unknown whether and how site 1, 2, 3 residues impact on 
biological Wnt function under relevant physiological conditions.  
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Fig.7. 3D structure of mouse Wnt3a-Fz8-CRD complex (A) Sequence alignment of 
Xenopus Wnt8 and mouse Wnt3a protein. Binding sites interacting with Fz8-CRD are 
marked, site 1 (green), site 2 (blue) and site 3 (red). (B) 3D model of mouse Wnt3a complex 
with Fz8-CRD showing the different binding sites. NTD, N-terminal domain, CTD, C-
terminal domain.  
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Table 16:  Interaction of  site 1, site 2, site 3 residues with Fz8-CRD in Wnt3a-Fz8-
CRD complex structure.  
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6.3 Mutational analysis of in vitro Wnt3a activity  
 
6.3.1 Effect of Site 1, site 2 and site 3 point mutants on Wnt signaling activity  
  
In order to investigate the importance of point mutants in Wnt3a responsible for Fz8-
CRD engagement, the corresponding interacting residues mutated to alanine whereas 
glycine, alanine and valine residues were mutated to arginine. Each Wnt3a mutant 
was analyzed for its biological activity in Wnt reporter assay. HEK 293T cells were 
transiently co-transfected with TCF-firefly, actin renilla luciferase reporter for 
normalizing and WT Wnt3a or mutant isoforms plasmid. For control Wnt3a plasmid 
transfection was omitted.  
 
It was observed that site 1 interaction was dominated by the lipid group attached to 
S209 in Wnt3a, while other mutations introduced into site 1 reduced signaling activity 
only moderately, with the exception of G210R, which revealed a dramatic loss in its 
signaling activity (Fig. 8A). As expected, mutation of the lipid attachment site S209 
completely abolished Wnt signaling activity. The other three mutants K204A, L208A, 
W218A had moderate effect on Wnt signaling activity. A combined mutation of 
K204A and L208A, which has only mild effect as individual mutant, the signaling 
activity loss was more pronounced (Fig. 9C). Mutations in site 2 generally showed a 
more pronounced effect on β-catenin-dependent transactivation of a luciferase 
reporter plasmid (TOPflash). In particular, C335A and V337R mutations resulted in a 
complete loss of the relative luciferase activity (Fig. 8C). Interestingly, alanine 
substitution of V337 did not alter the signaling efficiency of Wnt ligand (Fig. 9E). 
Mutant Y336A had no effect on signaling activity (Fig. 8C). While F331A and 
W333A single mutations still showed some residual signaling activity (Fig. 8C), but 
the double mutant F331A/W333A showed signaling activity comparable to vector 
control (Fig. 9C). Interestingly, it was observed that co-transfection of Wnt3a and 
V337R mutant, inhibit the Wnt signaling activity by 50%, suggesting there might be a 
competition between these two mutants for receptor binding.  
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Fig.8. Effect of Wnt3a site 1 and site 2 point mutations on signaling activity. (A, C) Wnt 
reporter assay for the activity of site 1 and site 2 mutants and compared with WT Wnt3a. 
HEK 293T cells were transiently cotransfected with luciferase bases TCF/Wnt and Actin 
Ranilla reporter with 5ng WT Wnt3a or indicated mutant isoforms. (B, D) Secretion level of 
Wnt3a mutants analyzed by Western blotting. HEK 293T cells transfected with WT Wnt3a or 
indicated mutant constructs. Conditioned medium (CM) and cell lysates (CL) were analyzed 
48 hours after transfection. Membranes were probed with anti-Wnt3a and anti-tubulin 
(loading control) antibodies. Error bars represent the standard deviation.  
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   Fig.9. Effect of Wnt3a site 3 and double mutants on signaling activity. (A) Wnt 
reporter assays for the activity of Site 3 mutants  (B, D, F) Secretion level of Wnt3a mutants 
analyzed by Western blotting. (C) Effect of double mutants on Wnt signaling activity. (E) 
The alanine substitution at V337 position (V337A) had no effect on activity in Wnt reporter 
assay. (G) Competitive binding result of Wnt3a and V337R in Wnt reporter assay. Error 
bars represent the standard deviation.  
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I further asked whether the predicted interaction residues in pseudo-site 3 were also 
involved in Wnt3a signaling activity. As a result it was found that site-directed 
mutations at site 3 positions, mutants V60R, E68A, F169A, significantly decreased 
signaling activity in the Wnt reporter assay (Fig 9A). The E68A/F169A double 
mutant did not show any residual activity (Fig. 9C). However in contrast to site 1 and 
site 2 mutations, the majority of the mutations introduced in the site 3 augmented Wnt 
signaling as compared to wild type Wnt3a (Fig. 9A). It was observed that A96R 
showing the most pronounced effect on signaling activity.  
 
Taken together these results lead to the conclusion, that Wnt3a CTD which harbor the 
binding site 2 has more pronounce effect on Fz binding, compared to NTD which 
comprise binding site 1. I have also observed that site 3 relevant for Wnt signaling, 
precluding a ‘pseudo’ contact likely caused by a crystal artifact (Janda et al, 2012). 
 
6.3.2 Secretion level of mutant Wnt proteins in HEK 293T cells  
 
To exclude the fact that observed activity loss resulted from impaired secretion of the 
mutant proteins, I analyzed the respective mutant protein levels in cell supernatants 
and cell lysates. For this, I transiently transfected HEK293T cells in 6 well plates with 
2 µg of each plasmid. For protein expression cells were grown in low serum medium 
for 48 hours. 20 µl of conditioned medium and 10 µl of cell lysates were submitted to 
SDS PAGE and analyzed by Western blotting using anti-Wnt3a primary antibody, 
alpha-tubulin was used as loading control in all experiments. The secretion levels of 
all mutant proteins from site 1, site 2 and site 3 did not grossly deviate from wild type 
Wnt3a protein (Fig. 8B, D) and (Fig. 9B, D, F) indicate that the mutations introduced 
did not significantly alter protein folding and secretion. The lowest levels were 
observed for S209A, which can be explained by impaired secretion due to the lack of 
lipid modification.  
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6.4 Impact of Wnt3a mutations for direct binding to Fz8-CRD 
 
In order to investigate whether the introduced Wnt3a mutations affected Wnt-Fz 
binding. A pull-down assay was performed using the recombinant mouse Fz8-CRD-
Fc fusion protein. As a negative control the Fc protein was applied. I purified 
recombinant Fz8-CRD-Fc and Fc protein from HEK293T cells (Fig. 10A). Cells were 
transiently transfected with 10 µg of corresponding plasmids. Conditioned medium 
was collected after 2 days of transfection and incubated with Protein G agarose for 3 
hours at 40C. Proteins were eluted with low pH elution buffer.  
 
As a result, it was observed that at least 80-90% of wild type Wnt3a is competent to 
specifically bind Fz8-CRD-Fc (Fig. 10B), but the binding of site 2 mutant W333A to 
the Fz8-CRD-Fc was nearly abolished when compared to the wild type, while C335A 
still had some residual binding activity (Fig. 10B). More surprisingly F331A and 
V337R mutations although lacking the signaling activity in Wnt reporter assay, 
showed full Fz8-CDR binding. The double mutant F331A/W333A binding was 
comparable to the W333A single mutant in the pull down assay (Fig. 10C). Site 1 
mutants, S209A and G210R, showed a complete loss of binding however, the site 1 
double mutant K204A/L208A showed no significant diminution in binding, 
confirming the previous results obtained from the Wnt reporter assay. Site 3 mutants 
V60R and E68A showed only minimal binding to Fz8-CRD, whereas mutant F169A 
and double mutant E68A/F169A completely failed to bind the receptor (Fz8-CRD) in 
the pull-down assay (Fig. 10C). In summary, our binding data indicate site 2 residues, 
F331 and V337, as being crucial for signaling without contributing Fz8-CRD binding. 
 
Taken together the results obtained from Wnt reporter assay of mutants and direct 
binding assay between Wnt and Fz, collectively elucidate the specific contribution of 
Wnt residues from different sites in Fz receptor signaling (Fig. 11). It was found that 
mutants from site 1, S209A and G210R contribute to Wnt signaling activity and direct 
Fz binding. In site 2, mutants W333A, C335A, contribute to both Wnt signaling 
activity and Fz binding, whereas F331A and V337R are crucial for signaling without 
contributing to the binding energy to the Fz8-CRD. In site 3, mutants V60R, E68A 
and F169A are critically important to both signaling activity and Fz binding. 
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Fig.10. Binding of Wnt3a mutants to Fz8-CRD-Fc. (A) Purification of Fz8-CRD-Fc and Fc 
protein (i) Coomassie-stained gel with Fz8-CRD-Fc and Fc fusion partner alone secreted from 
HEK 293T cells and purified with Protein G agarose. (ii) Immuno blot of purified protein 
with anti-human-IgG (Fc specific) anitbody (B) Binding efficiency of respective mutants 
from site 1 and site 2 was analyzed by precipitating from conditioned medium with 
recombinant Fz8-CRD-FC or Fc alone pre-bound to Protein G agarose beads. Bound protein 
fractions were analyzed by immunoblotting using anti-Wnt3a antibody. (C) Binding analysis 
of site 3 and double mutants to Fz8-CRD-Fc. 
             
 
 
 
 
 
    
 
 
 
 
Results  
	   65	  
 
 
 
 
Fig.11. Effect of different Wnt mutants in TCF/Wnt-reporter assays and Fz binding. (A) 
-, --, --- represent intermediate, low and no signaling activity. ++, +, - ND, represent full 
binding, low binding, no binding and binding not determined (B) Surface diagram of mouse 
Wnt3a-Fz8-CRD representing the residues of Wnt3a specific for Fz engagement. Residues 
highlighted in red are critical for both signaling activity and binding. Residues highlighted in 
blue responsible for signaling activity without contributing to Fz binding.  
 
 
6.5 Individual Wnt3a protein domains do not show independent 
signaling activity 
  
It was suggested that a mini-Wnt comprising the Xenopus Wnt8 CTD has similar 
binding specificity to Fz as the full-length Wnt ligand (Janda et al, 2012). However it 
is not known whether the mouse Wnt3a subdomains have an independent signaling 
property. To investigate this issue, I designed two expression construct Wnt3a NTD 
(1-276) and Wnt3a CTD (277-352) which, bear the native signal peptide (Fig. 12A) 
and evaluated their activity in vitro and in vivo.  
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For in vitro activity a Wnt reporter assay was used. As a result, it was found that 
constructs expressing Wnt3a subdomains i.e. Wnt3a NTD and CTD, did not activate 
Wnt reporter assay, neither alone nor in combination. (Fig. 12B).  However, when 
these single domains were co-transfected with full-length Wnt3a, both of them 
showed a moderate inhibition of the Wnt reporter activity likely by competing for 
receptor binding, with the CTD having a stronger inhibitory effect than the NTD. I 
have also observed the additive effect by combining both Wnt3a domains in triple co-
transfection experiments with full-length Wnt3a (Fig. 12B).   
 
To exclude the possibility that the loss of Wnt3a signaling activity resulted from 
abnormal cellular synthesis or secretion Wnt domain fragments Wnt3a NTD and CTD 
were expressed as His-tagged fusion protein in HEK293T cells. I further partially 
purified these proteins by incubating equal amounts of conditioned medium 
containing Wnt3a NTD and CTD proteins with Ni-NTA agarose and analyzed by 
Western blot using anti-his antibody. The calculated molecular masses are 31.4 kDa 
for Wnt3a NTD and 11.6 kDa for the CTD, respectively. An unspecific serum protein 
at about 17kDa was co-precipitated in all samples including vector control. The 
second band in the CTD lane at about 15kDa likely represents a different 
conformational state due to partial disulfide bonding. Taken together, it showed that 
both domains could be detected at similar level indicating sufficient structural 
integrity of the Wnt domains for passing the cellular protein folding control of the 
secretory pathway (Fig. 12C). 
 
 
6.5.1 Mouse Wnt3a NTD and CTD did not induce double axis in Xenopus 
embroys  
 
It has been known that mouse Wnt3a is a potent inducer of Wnt signaling in Xenopus, 
which itself provide a powerful system to characterize activation of Wnt signaling 
pathway. I performed double axis assay taking the advantage of the fact that ectopic 
expression of Wnt ligands can establish an additional organizer, leading to formation 
of a secondary dorsal axis (Sokol et al, 1991).  
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   Fig.12. In vitro and in vivo activity of Wnt3a NTD and CTD domains. (A) Schematic 
representation of applied mouse Wnt3a NTD and CTD constructs. (B) Wnt reporter assay in 
HEK293T showing the effect of Wnt3a NTD and CTD on signaling activity. (C) Western 
blot analysis showing the secretion level of Wnt3a NTD and CTD protein in HEK293T 
cells. (E-H) Xenopus embryos at 4-cell stage were injected into the ventral-marginal-zone 
with 3pg mRNA encoding (E) Wild type Wnt3a (F) NTD (G) CTD (H) NTD+CTD.  SP= 
signal peptide, NTD= N-terminal domain, CTD=C-terminal domain. (I) Statistical overview 
of mRNA injection experiment. 
 
 
To perform this experiment, I synthesized the capped mRNA from pCS2-Wnt3a NTD 
and CTD by linearzing the plasmid. For double axis experiment 3 pg of Wn3a NTD 
and CTD capped mRNA were injected in embryos at 4 cell-stage, injection of wild  
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type Wnt3a mRNA served as positive control. Embryos injected with 3 pg of wild 
type Wnt3a mRNA very effectively induced secondary axes, while the separate Wnt 
domains did not show a comparable effect, even at a ten or hundred-fold access of 
mRNA (Table 17). Consistently, a combined injection of equimolar mRNAs encoding 
for the Wnt3a domains also did not induce an in vivo activity (Fig. 12 D-H). This 
leads to conclude us that Wnt domains can fold independently but are not able to bind 
to Fz receptor effectively in an independent manner in the in vivo context. 
 	  Table 17: The effect of Wnt3a NTD and CTD mRNAs on secondary axis 
development in Xenopus embryos. Numbers represent total numbers of embryos. In 
combined injections the mRNAs were applied at equimolar concentrations. 
 
 
 
 
 
6.6 Physiological relevance of Wnt3a point mutations in zebrafish       
embryos  
 
To determine whether mouse Wnt3a point mutations have any effect on the Wnt3a 
function in vivo, I evaluated the activity of Wnt3a mutants that were found to be 
critical in vitro by their expression in the zebrafish embryo. Ectopic expression of 
Wnt antagonists can promote head formation, whereas ectopic activation of Wnt 
signaling during gastrulating blocks head formation (Niehrs, 1999). Furthermore, it  
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has been previously shown that over expression of zebrafish Wnt3 can activate the 
canonical Wnt pathway within the zebrafish embryo and block the head formation 
(Clements et al, 2009). To investigate mouse Wnt3a mutants in vivo, I injected 3pg 
mouse Wnt3a capped mRNA per embryo, which causes a very specific and robust 
effect on specifying the balance of anterior-posterior (A-P) cell fates along the neural 
axis in the zebrafish, resulting in severe posteriorization of the anterior nervous 
system (Fig. 13A, B). Using the optical sectioning, it was found that 2 pg of Wnt3a 
mRNA per embryo leads to the loss of the eye field, forebrain and partially also 
midbrain structure (Fig. 14B). These abnormalities were specific to the cranial part of 
the embryo, whereas the posterior part of the embryos showed no gross abnormalities. 
Injection of higher amounts of Wnt3a mRNA leads to severe abnormalities during 
gastrulating (Fig. 13) that were specific to high Wnt3a expression level only.  
 
If the point mutations in mouse Wnt3a were deleterious for their activity in vitro, then 
similar levels of the Wnt3a mutants would be expected to have no effect on A-P 
neural axis establishment. To investigate the above point I injected a set of Wnt3a 
mutant capped mRNAs at 2 pg per embryo and quantified the effects on the embryo 
development at 1.5 day post fertilization (dpf). Similar to wild type mouse Wnt3a, the 
mutants F331A, W333A, C335A, V60R, E68A, A96R and F169A lead to severe 
defects in the formation of anterior most neural system. They were characterized for 
lack of telencephalon and the eye field structure and occasionally also led to 
diminished mesencephalic structure when compared to the non-injected or the EF1 α 
control injected embryos (Fig. 14A). Interestingly, in the A96R mutant, the effects 
were most severe among all expressed constructs, where very frequently the complete 
cranial part of the embryonic axis was missing. In 24.8% of G210R expressing 
embryos the eyes were either not present or appeared to be significantly smaller in 
size. I was very intrigued by the finding that when the V337R mutant was expressed, 
81.3% of the injected embryos were normal and not distinguishable from the controls. 
Interestingly, from all injected constructs, each carrying a single mutations in Wnt3a, 
only S209A mutant mRNA injected embryos (94.7%) did not have any effect, neither 
on the formation of forebrain/midbrain nor on the eye field, suggesting S209A 
mutation as deleterious for in vivo function of Wnt3a. Double mutants, E68A/E169A 
and F331A/W333A, did not show any reversal of the phenotype and their effects were  
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Fig.13. Effect of ectopic mouse Wnt3a capped mRNA injections on zebrafish embryonic 
development. (A) Pictures of live embryos in lateral view. Anterior is to the left and posterior 
to the top. Note the effect of 3pg mouse Wnt3a mRNA injection on loss of eye field, and 
forebrain. Midbrain-hindbrain barrier (arrows) is still present. Upon injection of 33pg mouse 
Wnt3a mRNA or more, the embryos are not able to gastrulate properly. (B) Quantification of 
the effect of full-length wild-type mouse Wnt3a mRNA on zebrafish embryonic development. 
Number of embryos analyzed for each condition: non-injected n:65, 3pg n:81, 33pg n:82, 
100pg n:93, 150pg n:74. 
 
not significantly different from each single mutant at gross morphological level. 
Altogether, these results reveal that the mutations in F331A, W333A, C335A, V60R, 
E68A, A96R, F169A residues do not significantly impair Wnt3a in vivo signaling 
activity in this context.  Similar to the experiments from cultured HEK 293T cells, the 
S209A mutant completely lost the activity on zebrafish embryogenesis, suggesting its 
critical role in zebrafish embryo development. Interestingly, in this analysis V337R 
was indentified as the most essential residue required for signaling. 
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Fig. 14. Expression of mouse Wnt3a mutants in zebrafish embryos. (A) Lateral view of 
1.5 dpf old zebrafish embryos upon injection of capped mRNA encoding wild type and 
mutant mouse Wnt3a. Note lack of forebrain, eye field and midbrain structures in lateral 
view. (B) Posteriorizing effect of Wnt3a overexpression on zebrafish development as 
analyzed at 1.5 dpf. Pictures represent single optical sections either at lateral (upper panel) or 
medial (lower panel) sagittal sections in staining for F-actin marking cell outlines and thereby 
general nervous system morphology. Weaker phenotype with loss of retina and forebrain, 
whereas remnants of midbrain structures might be present termed as phenotype type I. 
Stronger phenotype (with lack of forebrain, retina, lens, midbrain) determined as phenotype 
type II. (C) Penetrance of the dorsalized phenotype in zebrafish embryogenesis upon wild 
type and mutant mouse Wnt3a expression, quantified as percentage. Type I (weaker) and type 
II (stronger) respond to the phenotypes as shown in Fig. 11B. Total number of embryos (n) 
from three independent experiments: non-injected:403, EF1a: 76, wild type mouse 
Wnt3a:224, S209A:113, G210R:96, F331A:79, W333A:54, C335A:91, V337R:139, 
V60R:86, E68A:64, A96R:124, F169A:82, E68A/F169A:88, F331A/W333A:82. In all 
panels: anterior is to the left and dorsal is up. Eyes are outlined with dashed pink line. Fb = 
forebrain, mb = midbrain, hb = hindbrain, r = retina, l= lens, ov = optic vesicle. 
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6.7 Quantification of mouse WT Wnt3a and mutants protein in HEK 
293T cells  
 
The amount of Wnt3a protein secreted into the medium was quantified by comparing 
it with various amount of purified recombinant mouse Wnt3a protein (R&D system). 
20 µl of the condition medium (CM) contained, ≈ 12 ng of the mouse Wnt3a protein, 
indicating that the concentration of Wnt3a protein was 0.6 µg/ml in the condition 
medium (Fig. 15). 
 
 Fig.15. Estimation of mouse Wnt3a concentration in conditioned medium of HEK293T   
cells. 20 µl of conditioned medium from HEK 293T cells expressing wild type mouse Wnt3a 
were blotted together with increasing amounts of commercial recombinant mouse Wnt3a 
using anti-Wnt3a antibody. The intensity of the Wnt3a band in conditioned medium was 
found to be between the intensities of the 10 and 25 ng bands. 
 
 
6.8 Soluble Fz8-CRD protein influences Wnt3a signaling in a       
biphasic manner  
 
The in vitro data obtained from TCF/Wnt reporter and pull down assay on site 2 
mutants W333A and C335A strongly suggested a major role of the Wnt3a CTD in Fz 
binding, leads to concluded that receptor engagement of the membrane-anchored Wnt 
is a two-step process, in which the initial interaction with the Wnt CTD facilitates 
membrane detachment of the lipid modified NTD. Soluble CRD proteins might 
therefore be able to augment Wnt signaling by the increasing local concentration of 
membrane-detached Wnt ligands at cell surface. To investigate this hypothesis, I 
performed a Wnt reporter assay in HEK 293T cells with wild type Wnt3a in presence  
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of Fz8-CRD-Fc protein at increasing concentration. HEK293T cells were transiently 
co-transfected with reporter constructs TCF-firefly, actin Renilla and wild type 
Wnt3a, after 24 hours post transfection recombinant Fz8-CRD-Fc protein at indicated 
concentrations was added on these Wnt3a producing cells. It was observed that 
soluble Fz8-CRD applied at micromolar concentrations inhibited Wnt signaling (Fig. 
16A). In contrast, CRD concentration that were in the range or slightly above the 
Wnt3a concentration in the cell supernatant (∼ 1 ng/µl) increases Wnt reporter activity 
by three-fold as compared to the Wnt3a alone, while Fc protein alone did not 
influence Wnt reporter activity.  
 
To confirm that the increase in Wnt reporter activity was due to a higher amount of 
soluble Wnt3a ligands, I transfected HEK 293T cells with wild type Wnt3a plasmid. 
After 24 hours of post-transfection cells were incubated with different amount of Fz8-
CRD-Fc protein and further monitored for Wnt3a protein levels in the cell 
supernatants by western blotting. The amount of soluble Wnt3a protein was to a large 
extent correlated with the applied Fz8-CRD concentration, while Fc protein alone did 
not induce Wnt3a detachment from the cell surface (Fig 16B). 
 
To provide further evidence that the observed increase in Wnt signaling activity by 
Fz8-CRD protein was due to a higher mobility of the Wnt ligands, a double chamber 
luciferase assay was performed, in which the LWnt3a transfected cells were separated 
from the responder cells, which were transfected with reporter plasmid by a porous 
membrane (Fig. 16C). The Fz8-CRD-Fc protein was applied at increasing 
concentration to the Wnt-producing cells.  As shown in Fig. 16D it was found that the 
luciferase activity of the responder cells was modulated by the soluble CRD protein in 
a comparable manner as in Fig. 16A, suggesting that the increase of signaling activity 
at nearly equimolar concentrations of Wnt3a and Fz8-CRD is independent from direct 
cell-cell contacts.  Taken together, these results clearly indicate that, Wnt3a activity 
was modulated by the presence of soluble CRD protein positively by increased 
solubility at low CRD concentrations and negatively at high CRD concentration. 
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Fig. 16. Modulation of Wnt signaling by soluble Fz8-CRD-Fc (A) Wnt reporter assay 
showing the influence of soluble mouse Fz8-CRD-Fc on Wnt signaling in a dose-dependent 
manner (B) Immunoblot depicting the influence of recombinant Fz8-CRD-Fc or Fc as 
negative control on the concentration of soluble Wnt3a protein in the cell supernatant. (C) 
Schematic representation of set up for double chamber luciferase assay in which responder 
cells were separated by Wnt producing cells via porous membrane. (D) Wnt reporter assay 
readout in which CMV-b-Galactosidase and Super TOPFlash reporter were transfected in 
HEK 293T cells.  The Fz8-CRD-Fc protein was applied at increasing concentrations to the 
Wnt producing cells. Luciferase activity was monitored in Wnt3a responder cells. 
Experiments were carried out in triplicate. Error bars depict standard deviation. 
 
 
 
 	  
Discussion 
	   75	  
 
7. Discussion  
Although the Wnt/Fz signaling pathway has been studied extensively at the cellular 
level, structure-function properties of Wnt ligands are poorly understood. In the 
present study, I demonstrate an in vitro and in vivo functional characterization of 
mouse Wnt3a-Fz8 binding interface. The mutations that were introduced in the Wnt3a 
sequence were directed by a model of the mouse Wnt3a-Fz8-CRD complex structure 
on the basis of the recently published X-ray structure (Janda et al, 2012) (Fig. 7B). 
The binding epitopes screen using the synthetic Wnt3a peptide library indicated 
several critical sites in accordance with those suggested by the crystal structure. 
Interestingly, a peptide comprising the lipid attachment residue showed the strongest 
effect although, lacking the lipid modification. This indicates that site 1 binding is not 
exclusively dependent on the presence of the lipid modification. The strong effect of 
G210R mutation underscores the importance of protein-protein interactions apart 
from the lipid-CRD interaction in site 1. The fact that none of the peptides induced a 
complete inhibition of Wnt signaling in cell culture competing for binding site with 
the full-length ligand argues against linear Wnt peptide fragments as potent inhibitors.  
This is in contrast to a study using peptide from the LRP6 binding domain of Dkk-1 
(Gregory et al, 2005) and might reflect a higher complexity of the Wnt-Fz interface. 
When I mutated residues in mouse Wnt3a responsible for site 1 interaction (Fig. 8) 
S209 mutation abolished signaling activity in the Wnt reporter assay completely, due 
to its function as lipid attachment site. The importance of the lipid modification in 
Wnt signaling has been repeatedly reported (Doubravska et al, 2011; Takada et al, 
2006; Tang et al, 2012; Willert et al, 2003). Interestingly, Ser209 mutation also led to 
a complete loss in binding to soluble Fz8-CRD (Fig. 10B), although the C-terminal 
Wnt domain was reported to be sufficient for binding in the absence of site 1 (Janda et 
al, 2012). In concert to this, it was also found that S209 to be crucial for Wnt3a 
activity in injected zebrafish embryos in vivo. Interestingly, S209 is highly conserved 
among members of Wnt family except Drosophila WntD. It can be concluded that the 
Fz interaction with the Wnt lipid might be necessary for the correct positioning of the 
ligand in the signaling complex and its stability.  
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In particular, LRP5/6 binding sites in the linker between sites 1 and 2 might be 
sensitive to lacking conformational restrictions imposed on this region (Chu et al, 
2013). Alternatively, the lack of lipid modification might induce protein aggregate 
formation precluding site 2 accessibility. It was found that G210R mutation also leads 
to a complete loss both in binding and activity, however alanine substitution at this 
position (G210A) has no effect on Wnt activity, suggesting that charged amino acids 
might disrupt interaction between Wnt and Fz. In zebrafish embryos G210R was still 
partially active, suggesting that the presence of the lipid attachment at site 1 alone is 
likely insufficient for full Wnt3a activity. Apparently, a distortion of the ‘‘thumb’’ 
loop interaction with Fz, can also lead to a largely dysfunctional ligand. The G210 
position is conserved among all Wnt ligands with the exception of medaka and 
zebrafish Wnt8-like, where it is substituted to glutamic acid (Yokoi et al, 2003). 
Considering the findings that substitution is supposed to result in a Wnt ligand with 
attenuated activity, which might have a distinct developmental function. Other 
conserved site 1 residues reported to contribute secondarily to Fz interaction (K204, 
L208, W218) in Xenopus Wnt8 showed moderate reduction in signaling activity of 
mouse Wnt3a, both as single mutants and in double mutant (K204/L208). 
 
As predicted by the structural data, site 2 mutations had more pronounce effect on 
signaling in the Wnt reporter assay (Fig. 8C). In particular mutations in residues 
F331, W333, C335 and V337 that engage in van der waals interactions at the tip of 
the Wnt ‘‘index finger’’ in the complex structure showed a dramatic loss of ligand 
activity when mutated to alanine. C335, which showed the strongest effect, forms a 
disulphide bond with Cys334. From the above result, it can be presumed that its 
mutation besides attenuating CRD interaction has an additional impact on the overall 
structure of the binding loop. When I tested these mutants in the physiological context 
of zebrafish embryogenesis, F331, W333 and C335 showed only mild deviations from 
the wild type Wnt3a, retaining most of their signaling capacity, which might be due to 
compensatory effects by a different receptor context or higher sensitivity of the 
responder tissue. The V337R substitution, which had the most severe effect on 
signaling in vitro and in vivo, probably induces a stronger conformational distortion of 
the binding loop due to the bulky Arg side chain. Accordingly, an alanine substitution 
at this position did not alter the signaling efficiency of the Wnt ligand. Interestingly,  
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V337R mutation did not significantly inhibit binding to Fz8-CRD in solution (Fig 
10B).  It can be concluded that this site can be considered as primarily essential for 
signaling without contributing to binding.  This result further strengthened by a very 
recent report on a naturally occurring Wnt1 mutation of valine to phenylalanine at 
position V337 (V335) causing osteogenesis imperfecta (OI) through impaired Wnt 
signaling (Fahiminiya et al, 2013). It was identified that residue V337, as being 
essential for Wnt3a activity during zebrafish embryogenesis is novel. I therefore 
concluded that the insertion of W333 into the hydrophobic pocket of the Fz receptor 
is a critical binding event in the Wnt CTD might well be independent from the 
signaling competence of the ligand-receptor complex.   
Among site 3 mutants that abolished signaling, F169 showed the most pronounce loss 
in binding, which is in accordance with the results of the peptide screen (Fig. 6C). 
Here, peptide 15, which harbors F169 as a central residue showed the strongest 
inhibitory effect as compared to peptides comprising other site 3 amino acids. It was 
found that several site 3 mutants are inactive Wnt signaling strongly suggests CRD 
dimer formation as a necessary step in receptor signaling as was already suggested by 
previous reports (Carron et al, 2003). Interestingly, position F169 in Wnts is highly 
conserved and the interacting site in Fz CRDs and sFRPS is either phenylalanine or 
tyrosine suggesting stacking interactions of the aromatic residues (Appendix 9.3). As 
F-F and F-Y pairs exhibits different binding energies (Chelli et al, 2002) this 
interaction might be relevant for ligand-receptor specificity. 
The present study also showed that separate domains of Wnt3a could be secreted but 
are unable to activate Fz receptor signaling in an independent manner in Wnt reporter 
assay and Xenopus embryos. Previous reports also showed that Drosophila Wg 
independent domains fold properly, but did not obtain evidence for the separate 
function (Wu & Nusse, 2002). 
The lipid modification of Wnts (Willert et al, 2003) most probably acts as membrane 
anchor brining the C-terminal domain into a membrane-distal position. I proposed a 
model that suggests a sequential binding of Wnt to Fz-CRD protein, in which the first 
contact to the Fz-CRD and other CRD related proteins might therefore be realized via  
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Fig.17. Model for Wnt-CRD complex formation. (A) Sequential binding of membrane-
associated Wnt ligands to CRDs. The first binding step is realized between the membrane-
distal Wnt CTD and Fz-CRD or other CRD-related proteins via site 2 interaction. This 
facilitates membrane detachment of the Wnt NTD and a switch of the lipid chain into the site 
1 binding pocket. (B) Biphasic modulation of Wnt activity by CRD proteins. At low 
concentrations of CRD proteins active Wnt-CRD complexes are formed by Wnt mobilization 
and transfer to Fz receptors. At high CRD concentrations oligomerization is induced via site 3 
interaction, leading to trapping of Wnt ligands in inactive Wnt-CRD aggregates. 
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site 2, which in the second step facilitates membrane detachment and a switch of the 
lipid chain into the site 1 binding pocket, (Fig. 17A). Soluble CRD-related proteins 
should therefore effectively increase the amount of cell-detached Wnt ligands. In 
accordance with this, the spatial signaling range of Wnt was increased significantly by 
sFRP in vivo (Mii & Taira, 2009). Our data on the modulatory activity of Fz8-CRD-
Fc proteins on Wnt signaling clearly support such mechanism.  
In particular, by using the Wnt reporter assay with separated chambers for Wnt 
producing and responding cells, I was able to demonstrate that the presence of soluble 
CRD proteins is able to promote Wnt activity by facilitating mobility. This hypothesis 
was additionally investigated by designing fusion protein in which the Fz8-CRD was 
covalently linked to the N or C-terminus of Wnt3a via a flexible linker.  
 
 
Fig.18. Secretion and activity of a Wnt3a-Fz8-CRD fusion protein. (A) Schematic 
representation of Wnt3a-Fz8-CRD fusion protein. (B) Secretion levels of His-tagged Wnt3a 
and Wnt3a-Fz8-CRD fusion protein. Precipitated proteins from equal amounts of conditioned 
medium were analyzed by Western blot using anti-his antibody (C) Wnt3a-Fz8-CRD fusion 
protein did not induce Wnt signaling activity in Wnt reporter assay. Error bars depict standard 
deviation. 
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The level of these fusion proteins in conditioned medium were highly increased 
compared to Wnt3a alone indicating enhanced solubility by the presence of the CRD 
moiety (Fig. 18B). Mutants that inhibit this process would accordingly increase the 
concentration of active Wnt-CRD complexes, which facilitate efficient receptor 
engagement. The severe effect of the A96R mutation in the zebrafish embryo together 
with its pronounced activity in the Wnt reporter assay strongly support such a model 
and suggest this mutant as a possible new tool for the field representing a hyperactive 
Wnt ligand. 
 
7.1 Conclusions and Outlook  
In summary, a comparison of our results obtained from in vitro and in vivo analysis 
provides novel important insights into structure function relationships of the Wnt3a-
Fz8 binding interface and its modulation by soluble CRD-related proteins. The 
dissection of Wnt3a residues into sites essential for binding and for signaling will 
clearly suggest new approaches to tackle the problem of ligand-receptor specificity in 
the Wnt field. This could help in the design of potent Wnt agonists and antagonist that 
mimic the ability of Wnt to bind to multiple biologically relevant sites. This may have 
therapeutic implication in treating Wnt related diseases.  In particular, our analysis of 
site 3 residues that likely induce CRD homo or hetero dimers might improve our 
understanding of different signaling in the context of different receptors and soluble 
CRD-related factors. 	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9. Appendix  
 
9.1 Abbreviations  
 
a-p                                        Antero-posterior  
APC                                     Adenomatous polyposis coli 
APS                                      Ammonium Persulphate  
BMP                                    Bone morphogenetic protein  
BSA                                     Bovine Serum Albumin 
bp                                         Base pairs  
C. elegans                            Caenorhabditis elegans (roundworm)  
CKI                                      Casein  Kinase I 
CoIP                                    Co-immunoprecipitation  
D. melanogaster                  Drosophila melanogaster (fruit fly)  
Dkk                                      Dickkopf  
DNase                                  Deoxyribonuclease  
nNTP                                   Deoxyribonucleoside triphosphates  
DTT                                     1,4- Dithiothreitol  
d-v                                        Dorso-ventral  
Dvl                                       Dishevelled  
EDTA                                   Sodium ethylendiaminotetraacetate  
FCS                                      Fetal calf serum 
EGF                                      Epidermal growth factor  
ER                                        Endoplasmic reticulum  
FGF                                      Fibroblast growth factor  
Fz                                         Frizzled receptor  
GK3β                                   Glycogen synthase kinase 3  
kDa                                       kiloDalton  
Krm                                      Kremen  
LB                                        Luria-Bertani  
LDLR                                   Low density lipoprotein receptor  
LRP                                      Lipoprotein receptor-related protein  
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M                                          Molar  
min                                       Minutes  
mRNA                                  messenger RNA 
µl                                          microliter 
µg                                         microgram 
PAGE                                   Polyacrylamide gel electrophoresis 
PBS                                      Phosphate-buffered saline 
PDB                                      Protein data bank 
PCP                                       planar cell polarity 
PCR                                      polymerase chain reaction 
RT                                         Room temperature 
SDS                                       Sodium dodecyl sulphate 
sFRP                                      Secreted Frizzled-related protein 
TCF                                       T-cell factor 
TEMED                                 N,N,N’,N’-tetramethyethylenediamine 
Tris                                        Tris(hydroxymethyl)-amino-methane 
UV                                         Ultraviolet 
WT                                         Wild type 
X-Gal                                     5-bromo-4-chloro-3-indolyl-β-D-galactopyranoside 
X. laevis                                 Xenopus laevis (African clawed frog) 
 
Amino Acids  
 
  A    Ala     alanine                          I     lIe      isoleucine                    R    Arg    arginine 
  C    Cys    cysteine                         K    Lys     lysine                         S     Ser     serine 
  E     Asp    aspartic acid                 L     Leu    leucine                       T     Thr    threonine 
  D    Glu     glutamic acid               M    Met    methionine                V     Val    valine 
    F    Phe      phenylalanine              N    Asn    asparagine                  W    Trp   tryptophan 
  G    Gly     glycine                         P    Pro     Proline                        Y     Tyr   tyrosine 
  H    His      histidine                      Q    Gln    glutamine 
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9.2 Multiple sequence alignment of mouse Wnts  
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Fig.19 Multiple sequence alignment of mouse Wnts. Sequences were aligned with Clustal W 
(Chenna et al, 2003) and ESPript (Gouet et al, 2003). Invariant residues are shown as white text 
in red boxes. Conserved residues are shown in red text in white boxes. Interacting residues from 
different binding sites are marked with different colors. Site 1 interacting residues marked with 
green square, Site 2 residues are marked with blue circle and site 3 residues are marked with 
violet triangle.  
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9.3 Multiple sequence alignment of Fz8-CRD and sFRPs from different organisms  
 
 
 
Fig.20. Multiple sequence alignment of Fz8-CRD and sFRPs. Sequences were aligned with 
Clustal W (Chenna et al, 2003) and ESPript (Gouet et al, 2003). Invariant residues are shown as 
white text in red boxes. Conserved residues are shown in red text in white boxes. The F169 
residue from site 3 either which is highly conserved in all Wnts interact with and interacting site 
in Fz CRDs and sFRPs is either phenylalanine or tyrosine (marked with green arrow). 
Mus musculus (Mm), Homo sapiens (Hs), Xenopus laevis (Xl), Danio rerio (Dr), Nematostella 
vectensis (Nv). 
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